JAMES WILLERSON

TitleAdjunct Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Research 
    Collapse research activities and funding
    P50HL017669     (SAMBROOK, JOSEPH)Jan 1, 1975 - Dec 31, 1994
    NIH/NHLBI
    SCOR IN CORONARY AND VASCULAR DISEASES
    Role: Co-Principal Investigator

    N01HV072942     (WILLERSON, JAMES T)Sep 15, 1977 - Jul 14, 1986
    NIH/NHLBI
    THERAPY TO PROTECT ISCHEMIC MYOCARDIUM/CLINICAL TESTS
    Role: Principal Investigator

    T32HL007591     (TAEGTMEYER, HEINRICH)Jul 1, 1985 - Jun 30, 2005
    NIH/NHLBI
    MOLECULAR AND CELLULAR MECHANISMS OF HEART DISEASE
    Role: Co-Principal Investigator

    R01HL050179     (WILLERSON, JAMES T.)Jun 1, 1993 - May 31, 1998
    NIH/NHLBI
    CORONARY ARTERY RESTENOSIS--A MAJOR CARDIOLOGY PROBLEM
    Role: Principal Investigator

    R01HL054839     (WILLERSON, JAMES T.)Aug 1, 1996 - Apr 30, 2001
    NIH/NHLBI
    PREVENTION OF THROMBOSIS IN ANGIOPLASTY INJURED ARTERIES
    Role: Principal Investigator

    U01HL087365     (WILLERSON, JAMES T.)Jan 1, 2007 - Feb 29, 2012
    NIH/NHLBI
    Cardiovascular Cell Therapy Research Network
    Role: Principal Investigator

    UM1HL087365     (WILLERSON, JAMES T.)Jan 1, 2007 - Feb 28, 2019
    NIH/NHLBI
    Cardiovascular Cell Therapy Research Network
    Role: Principal Investigator

    P30HL101336     (WILLERSON, JAMES T.)Sep 30, 2009 - Aug 31, 2012
    NIH/NHLBI
    New Cardiovascular Research Scientist for Molecular and Cellular Biology Core
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Masso AH, Uribe C, Willerson JT, Cheong BY, Davis BR. Left Ventricular Noncompaction Detected by Cardiac Magnetic Resonance Screening: A Reexamination of Diagnostic Criteria. Tex Heart Inst J. 2020 Jun 01; 47(3):183-193. PMID: 32997774.
      Citations:    Fields:    
    2. Hernández-Rivera M, Cho SY, Moghaddam SE, Cheong BY, Cabreira-Hansen MDG, Willerson JT, Perin EC, Wilson LJ. Labeling Stem Cells with a New Hybrid Bismuth/Carbon Nanotube Contrast Agent for X-Ray Imaging. Contrast Media Mol Imaging. 2019; 2019:2183051. PMID: 31281232.
      Citations:    Fields:    Translation:HumansAnimalsCells
    3. Willerson JT. The Medical and Device-Related Treatment of Heart Failure. Circ Res. 2019 05 24; 124(11):1519. PMID: 31120816.
      Citations: 1     Fields:    Translation:HumansAnimals
    4. Cheedipudi SM, Matkovich SJ, Coarfa C, Hu X, Robertson MJ, Sweet M, Taylor M, Mestroni L, Cleveland J, Willerson JT, Gurha P, Marian AJ. Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy. Circ Res. 2019 04 12; 124(8):1198-1213. PMID: 30739589.
      Citations: 12     Fields:    Translation:HumansCells
    5. Taylor DA, Willerson JT. Racial Disparities in CD34+ Cells and Their Influence on Cardiovascular Repair. Circ Res. 2018 08 03; 123(4):401-403. PMID: 30355257.
      Citations:    Fields:    Translation:Cells
    6. Angelini P, Cheong BY, Lenge De Rosen VV, Lopez A, Uribe C, Masso AH, Ali SW, Davis BR, Muthupillai R, Willerson JT. High-Risk Cardiovascular Conditions in Sports-Related Sudden Death: Prevalence in 5,169 Schoolchildren Screened via Cardiac Magnetic Resonance. Tex Heart Inst J. 2018 08; 45(4):205-213. PMID: 30374227.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    7. Moghaddam SE, Hernández-Rivera M, Zaibaq NG, Ajala A, da Graça Cabreira-Hansen M, Mowlazadeh-Haghighi S, Willerson JT, Perin EC, Muthupillai R, Wilson LJ. A New High-Performance Gadonanotube-Polymer Hybrid Material for Stem Cell Labeling and Tracking by MRI. Contrast Media Mol Imaging. 2018; 2018:2853736. PMID: 30116161.
      Citations:    Fields:    Translation:AnimalsCells
    8. Bolli R, Hare JM, March KL, Pepine CJ, Willerson JT, Perin EC, Yang PC, Henry TD, Traverse JH, Mitrani RD, Khan A, Hernandez-Schulman I, Taylor DA, DiFede DL, Lima JAC, Chugh A, Loughran J, Vojvodic RW, Sayre SL, Bettencourt J, Cohen M, Moyé L, Ebert RF, Simari RD. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure). Circ Res. 2018 06 08; 122(12):1703-1715. PMID: 29703749.
      Citations: 16     Fields:    Translation:HumansCellsCTClinical Trials
    9. Bolli R, Hare JM, Henry TD, Lenneman CG, March KL, Miller K, Pepine CJ, Perin EC, Traverse JH, Willerson JT, Yang PC, Gee AP, Lima JA, Moyé L, Vojvodic RW, Sayre SL, Bettencourt J, Cohen M, Ebert RF, Simari RD. Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial. Am Heart J. 2018 07; 201:54-62. PMID: 29910056.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    10. Marian AJ, Tan Y, Li L, Chang J, Syrris P, Hessabi M, Rahbar MH, Willerson JT, Cheong BY, Liu CY, Kleiman NS, Bluemke DA, Nagueh SF. Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study. Circ Res. 2018 04 13; 122(8):1109-1118. PMID: 29540445.
      Citations: 4     Fields:    Translation:Humans
    11. Woodside DG, Tanifum EA, Ghaghada KB, Biediger RJ, Caivano AR, Starosolski ZA, Khounlo S, Bhayana S, Abbasi S, Craft JW, Maxwell DS, Patel C, Stupin IV, Bakthavatsalam D, Market RV, Willerson JT, Dixon RAF, Vanderslice P, Annapragada AV. Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin a4ß1. Sci Rep. 2018 02 27; 8(1):3733. PMID: 29487319.
      Citations: 2     Fields:    Translation:AnimalsCells
    12. Angelini P, Cheong BY, Lenge De Rosen VV, Lopez JA, Uribe C, Masso AH, Ali SW, Davis BR, Muthupillai R, Willerson JT. Magnetic Resonance Imaging-Based Screening Study in a General Population of Adolescents. J Am Coll Cardiol. 2018 02 06; 71(5):579-580. PMID: 29406865.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    13. Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Pinto FJ, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC. Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations: A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine. Circ Res. 2018 01 19; 122(2):199-201. PMID: 29348246.
      Citations: 3     Fields:    Translation:Humans
    14. Auguste G, Gurha P, Lombardi R, Coarfa C, Willerson JT, Marian AJ. Suppression of Activated FOXO Transcription Factors in the Heart Prolongs Survival in a Mouse Model of Laminopathies. Circ Res. 2018 03 02; 122(5):678-692. PMID: 29317431.
      Citations: 8     Fields:    Translation:AnimalsCells
    15. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Chugh A, Yang PC, Zhao DXM, Ellis SG, Forder JR, Perin EC, Penn MS, Hatzopoulos AK, Chambers JC, Baran KW, Raveendran G, Gee AP, Taylor DA, Moyé L, Ebert RF, Simari RD. TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis. Circ Res. 2018 02 02; 122(3):479-488. PMID: 29208679.
      Citations: 9     Fields:    Translation:Humans
    16. Haidari M, Zhang W, Willerson JT, Dixon RAF. Correction to: Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-ß-dependent vascular endothelial cadherin tyrosine phosphorylation. Cardiovasc Diabetol. 2017 10 20; 16(1):136. PMID: 29058597.
      Citations:    Fields:    
    17. Karmouch J, Zhou QQ, Miyake CY, Lombardi R, Kretzschmar K, Bannier-Hélaouët M, Clevers H, Wehrens XHT, Willerson JT, Marian AJ. Distinct Cellular Basis for Early Cardiac Arrhythmias, the Cardinal Manifestation of Arrhythmogenic Cardiomyopathy, and the Skin Phenotype of Cardiocutaneous Syndromes. Circ Res. 2017 Dec 08; 121(12):1346-1359. PMID: 29018034.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    18. Leach JP, Heallen T, Zhang M, Rahmani M, Morikawa Y, Hill MC, Segura A, Willerson JT, Martin JF. Hippo pathway deficiency reverses systolic heart failure after infarction. Nature. 2017 10 12; 550(7675):260-264. PMID: 28976966.
      Citations: 49     Fields:    Translation:HumansAnimalsCells
    19. Fernández-Avilés F, Sanz-Ruiz R, Climent AM, Badimon L, Bolli R, Charron D, Fuster V, Janssens S, Kastrup J, Kim HS, Lüscher TF, Martin JF, Menasché P, Simari RD, Stone GW, Terzic A, Willerson JT, Wu JC. Global position paper on cardiovascular regenerative medicine. Eur Heart J. 2017 09 01; 38(33):2532-2546. PMID: 28575280.
      Citations: 22     Fields:    Translation:Humans
    20. Martin JF, Perin EC, Willerson JT. Direct Stimulation of Cardiogenesis: A New Paradigm for Treating Heart Disease. Circ Res. 2017 06 23; 121(1):13-15. PMID: 28642324.
      Citations: 2     Fields:    Translation:HumansAnimals
    21. Willerson JT. The Texas Heart Institute: Part 1-An Historical Perspective. Circ Res. 2017 05 12; 120(10):1545-1547. PMID: 28495989.
      Citations:    Fields:    Translation:Humans
    22. Willerson JT. The Texas Heart Institute: Part 2-Working Toward the Next Breakthrough in Cardiovascular Medicine. Circ Res. 2017 05 12; 120(10):1548-1550. PMID: 28495990.
      Citations:    Fields:    Translation:Humans
    23. Li L, Bainbridge MN, Tan Y, Willerson JT, Marian AJ. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder. Circ Res. 2017 Mar 31; 120(7):1084-1090. PMID: 28223422.
      Citations: 9     Fields:    Translation:Humans
    24. Barac YD, Emrich F, Krutzwakd-Josefson E, Schrepfer S, Sampaio LC, Willerson JT, Robbins RC, Ciechanover A, Mohr FW, Aravot D, Taylor DA. The ubiquitin-proteasome system: A potential therapeutic target for heart failure. J Heart Lung Transplant. 2017 Jul; 36(7):708-714. PMID: 28341100.
      Citations: 4     Fields:    Translation:HumansCells
    25. Willerson JT. CD133+ Stem Cells in the Treatment of Patients With Refractory Angina. Circ Res. 2017 02 17; 120(4):602-603. PMID: 28209787.
      Citations: 1     Fields:    Translation:HumansCells
    26. Perin EC, Murphy MP, March KL, Bolli R, Loughran J, Yang PC, Leeper NJ, Dalman RL, Alexander J, Henry TD, Traverse JH, Pepine CJ, Anderson RD, Berceli S, Willerson JT, Muthupillai R, Gahremanpour A, Raveendran G, Velasquez O, Hare JM, Hernandez Schulman I, Kasi VS, Hiatt WR, Ambale-Venkatesh B, Lima JA, Taylor DA, Resende M, Gee AP, Durett AG, Bloom J, Richman S, G'Sell P, Williams S, Khan F, Gyang Ross E, Santoso MR, Goldman J, Leach D, Handberg E, Cheong B, Piece N, DiFede D, Bruhn-Ding B, Caldwell E, Bettencourt J, Lai D, Piller L, Simpson L, Cohen M, Sayre SL, Vojvodic RW, Moyé L, Ebert RF, Simari RD, Hirsch AT. Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells). Circulation. 2017 Apr 11; 135(15):1417-1428. PMID: 28209728.
      Citations: 13     Fields:    Translation:HumansCellsCTClinical Trials
    27. Fred HL, Willerson JT. Fare Thee Well, Dr. Cooley. Tex Heart Inst J. 2017 02; 44(1):3-6. PMID: 28265204.
      Citations:    Fields:    Translation:Humans
    28. Willerson JT. Denton Arthur Cooley, MD. Circ Res. 2017 01 06; 120(1):17-19. PMID: 28057783.
      Citations:    Fields:    
    29. Contreras A, Orozco AF, Resende M, Schutt RC, Traverse JH, Henry TD, Lai D, Cooke JP, Bolli R, Cohen ML, Moyé L, Pepine CJ, Yang PC, Perin EC, Willerson JT, Taylor DA. Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials. Basic Res Cardiol. 2017 01; 112(1):3. PMID: 27882430.
      Citations: 2     Fields:    Translation:HumansCells
    30. Henry TD, Pepine CJ, Lambert CR, Traverse JH, Schatz R, Costa M, Povsic TJ, David Anderson R, Willerson JT, Kesten S, Perin EC. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction. Catheter Cardiovasc Interv. 2017 Feb 01; 89(2):169-177. PMID: 27148802.
      Citations: 25     Fields:    Translation:Humans
    31. Gurha P, Chen X, Lombardi R, Willerson JT, Marian AJ. Knockdown of Plakophilin 2 Downregulates miR-184 Through CpG Hypermethylation and Suppression of the E2F1 Pathway and Leads to Enhanced Adipogenesis In Vitro. Circ Res. 2016 Sep 02; 119(6):731-50. PMID: 27470638.
      Citations: 13     Fields:    Translation:AnimalsCells
    32. Bhatnagar A, Bolli R, Johnstone BH, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Yang PC, Cooke JP, Schutt RC, Trachtenberg BH, Orozco A, Resende M, Ebert RF, Sayre SL, Simari RD, Moyé L, Cogle CR, Taylor DA. Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial. Am Heart J. 2016 09; 179:142-50. PMID: 27595689.
      Citations: 3     Fields:    Translation:HumansCells
    33. Lombardi R, Chen SN, Ruggiero A, Gurha P, Czernuszewicz GZ, Willerson JT, Marian AJ. Cardiac Fibro-Adipocyte Progenitors Express Desmosome Proteins and Preferentially Differentiate to Adipocytes Upon Deletion of the Desmoplakin Gene. Circ Res. 2016 06 24; 119(1):41-54. PMID: 27121621.
      Citations: 24     Fields:    Translation:HumansAnimalsCells
    34. Kumar VA, Liu Q, Wickremasinghe NC, Shi S, Cornwright TT, Deng Y, Azares A, Moore AN, Acevedo-Jake AM, Agudo NR, Pan S, Woodside DG, Vanderslice P, Willerson JT, Dixon RA, Hartgerink JD. Treatment of hind limb ischemia using angiogenic peptide nanofibers. Biomaterials. 2016 08; 98:113-9. PMID: 27182813.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    35. Deng Y, Yang Z, Terry T, Pan S, Woodside DG, Wang J, Ruan K, Willerson JT, Dixon RA, Liu Q. Prostacyclin-producing human mesenchymal cells target H19 lncRNA to augment endogenous progenitor function in hindlimb ischaemia. Nat Commun. 2016 Apr 15; 7:11276. PMID: 27080438.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    36. Madonna R, Van Laake LW, Davidson SM, Engel FB, Hausenloy DJ, Lecour S, Leor J, Perrino C, Schulz R, Ytrehus K, Landmesser U, Mummery CL, Janssens S, Willerson J, Eschenhagen T, Ferdinandy P, Sluijter JP. Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. Eur Heart J. 2016 06 14; 37(23):1789-98. PMID: 27055812.
      Citations: 60     Fields:    Translation:Humans
    37. Willerson JT. Focus on ECGs: A New Feature of the Texas Heart Institute Journal. Tex Heart Inst J. 2016 Feb; 43(1):1. PMID: 27047275.
      Citations:    Fields:    Translation:Humans
    38. Angelini P, Willerson JT. Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrest and the New Policy for Involving Schoolchildren. Tex Heart Inst J. 2015 Dec; 42(6):508-9. PMID: 26664299.
      Citations:    Fields:    Translation:Humans
    39. Taylor DA, Perin EC, Willerson JT, Zierold C, Resende M, Carlson M, Nestor B, Wise E, Orozco A, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Traverse JH, Cooke JP, Schutt RC, Bhatnagar A, Grant MB, Lai D, Johnstone BH, Sayre SL, Moyé L, Ebert RF, Bolli R, Simari RD, Cogle CR. Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial. Cell Transplant. 2016; 25(9):1675-1687. PMID: 26590374.
      Citations: 7     Fields:    Translation:HumansCells
    40. Willerson JT. In Memoriam: Kanu Chatterjee, MD (1934–2015). Tex Heart Inst J. 2015 Aug; 42(4):303-4. PMID: 26668982.
      Citations:    Fields:    Translation:Humans
    41. Angelini P, Uribe C, Monge J, Tobis JM, Elayda MA, Willerson JT. Origin of the right coronary artery from the opposite sinus of Valsalva in adults: characterization by intravascular ultrasonography at baseline and after stent angioplasty. Catheter Cardiovasc Interv. 2015 Aug; 86(2):199-208. PMID: 26178792.
      Citations: 8     Fields:    Translation:Humans
    42. Perin EC, Borow KM, Silva GV, DeMaria AN, Marroquin OC, Huang PP, Traverse JH, Krum H, Skerrett D, Zheng Y, Willerson JT, Itescu S, Henry TD. A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure. Circ Res. 2015 Aug 28; 117(6):576-84. PMID: 26148930.
      Citations: 48     Fields:    Translation:HumansCTClinical Trials
    43. Gizzatov A, Hernández-Rivera M, Keshishian V, Mackeyev Y, Law JJ, Guven A, Sethi R, Qu F, Muthupillai R, Cabreira-Hansen Mda G, Willerson JT, Perin EC, Ma Q, Bryant RG, Wilson LJ. Surfactant-free Gd(3+)-ion-containing carbon nanotube MRI contrast agents for stem cell labeling. Nanoscale. 2015 Jul 28; 7(28):12085-91. PMID: 26119138.
      Citations: 4     Fields:    Translation:AnimalsCells
    44. Willerson JT, Cooley DA, Rasekh A, Hall RJ. In memoriam: Ali Massumi, MD (1945-2015). Tex Heart Inst J. 2015 Jun; 42(3):191-2. PMID: 26387153.
      Citations:    Fields:    
    45. Willerson JT, Cabreira-Hansen MG, Taylor DA, Perin EC. Changing of the guard? Eur Heart J. 2015 Jul 14; 36(27):1711-3. PMID: 26022009.
      Citations:    Fields:    Translation:Humans
    46. Sánchez PL, Fernández-Santos ME, Costanza S, Climent AM, Moscoso I, Gonzalez-Nicolas MA, Sanz-Ruiz R, Rodríguez H, Kren SM, Garrido G, Escalante JL, Bermejo J, Elizaga J, Menarguez J, Yotti R, Pérez del Villar C, Espinosa MA, Guillem MS, Willerson JT, Bernad A, Matesanz R, Taylor DA, Fernández-Avilés F. Acellular human heart matrix: A critical step toward whole heart grafts. Biomaterials. 2015 Aug; 61:279-89. PMID: 26005766.
      Citations: 35     Fields:    Translation:HumansCells
    47. Morikawa Y, Zhang M, Heallen T, Leach J, Tao G, Xiao Y, Bai Y, Li W, Willerson JT, Martin JF. Actin cytoskeletal remodeling with protrusion formation is essential for heart regeneration in Hippo-deficient mice. Sci Signal. 2015 May 05; 8(375):ra41. PMID: 25943351.
      Citations: 53     Fields:    Translation:HumansAnimalsCells
    48. Willerson JT. Stem cell therapy for cardiovascular diseases: a progressive journey. Curr Opin Cardiol. 2015 May; 30(3):205-12. PMID: 25695897.
      Citations: 3     Fields:    Translation:Humans
    49. Willerson JT. In memoriam: Joseph K. Perloff (1924–2014). Tex Heart Inst J. 2015 Apr; 42(2):103-4. PMID: 26054085.
      Citations:    Fields:    Translation:Humans
    50. Madonna R, Ferdinandy P, De Caterina R, Willerson JT, Marian AJ. Recent developments in cardiovascular stem cells. Circ Res. 2014 Dec 05; 115(12):e71-8. PMID: 25477490.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    51. Schutt RC, Trachtenberg BH, Cooke JP, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Bhatnagar A, Johnstone BH, Lai D, Resende M, Ebert RF, Wu JC, Sayre SL, Orozco A, Zierold C, Simari RD, Moyé L, Cogle CR, Taylor DA. Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial. Circ Res. 2015 Jan 02; 116(1):99-107. PMID: 25406300.
      Citations: 15     Fields:    Translation:HumansCells
    52. Willerson JT, Taylor D, Perin EC. Till truth makes all things plain: human hearts and stem cells. Circ Res. 2014 Nov 07; 115(11):908-10. PMID: 25378531.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    53. Cogle CR, Wise E, Meacham AM, Zierold C, Traverse JH, Henry TD, Perin EC, Willerson JT, Ellis SG, Carlson M, Zhao DX, Bolli R, Cooke JP, Anwaruddin S, Bhatnagar A, da Graca Cabreira-Hansen M, Grant MB, Lai D, Moyé L, Ebert RF, Olson RE, Sayre SL, Schulman IH, Bosse RC, Scott EW, Simari RD, Pepine CJ, Taylor DA. Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes. Circ Res. 2014 Oct 24; 115(10):867-74. PMID: 25136078.
      Citations: 20     Fields:    Translation:HumansCells
    54. Haidari M, Zhang W, Willerson JT, Dixon RA. Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-ß-dependent vascular endothelial cadherin tyrosine phosphorylation. Cardiovasc Diabetol. 2014 Jul 15; 13:105. PMID: 25927959.
      Citations: 10     Fields:    Translation:HumansCells
    55. Perin EC, Sanz-Ruiz R, Sánchez PL, Lasso J, Pérez-Cano R, Alonso-Farto JC, Pérez-David E, Fernández-Santos ME, Serruys PW, Duckers HJ, Kastrup J, Chamuleau S, Zheng Y, Silva GV, Willerson JT, Fernández-Avilés F. Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial. Am Heart J. 2014 Jul; 168(1):88-95.e2. PMID: 24952864.
      Citations: 65     Fields:    Translation:HumansCells
    56. Cooley DA, Willerson JT. In memoriam: Mavis P. Kelsey, Sr. (1912-2013). Tex Heart Inst J. 2014 Apr; 41(2):121-2. PMID: 24919213.
      Citations:    Fields:    Translation:Humans
    57. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Ellis SG. One-year follow-up of intracoronary stem cell delivery on left ventricular function following ST-elevation myocardial infarction. JAMA. 2014 Jan 15; 311(3):301-2. PMID: 24247415.
      Citations: 12     Fields:    Translation:Humans
    58. Heallen T, Morikawa Y, Leach J, Tao G, Willerson JT, Johnson RL, Martin JF. Hippo signaling impedes adult heart regeneration. Development. 2013 Dec; 140(23):4683-90. PMID: 24255096.
      Citations: 128     Fields:    Translation:AnimalsCells
    59. Chen SN, Gurha P, Lombardi R, Ruggiero A, Willerson JT, Marian AJ. The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy. Circ Res. 2014 Jan 31; 114(3):454-68. PMID: 24276085.
      Citations: 78     Fields:    Translation:HumansAnimalsCells
    60. Tran LA, Hernández-Rivera M, Berlin AN, Zheng Y, Sampaio L, Bové C, Cabreira-Hansen Mda G, Willerson JT, Perin EC, Wilson LJ. The use of gadolinium-carbon nanostructures to magnetically enhance stem cell retention for cellular cardiomyoplasty. Biomaterials. 2014 Jan; 35(2):720-6. PMID: 24148239.
      Citations: 6     Fields:    Translation:AnimalsCells
    61. Rivera EJ, Tran LA, Hernández-Rivera M, Yoon D, Mikos AG, Rusakova IA, Cheong BY, Cabreira-Hansen MD, Willerson JT, Perin EC, Wilson LJ. Bismuth@US-tubes as a Potential Contrast Agent for X-ray Imaging Applications. J Mater Chem B. 2013 Oct 07; 1(37). PMID: 24288589.
      Citations: 6     Fields:    
    62. Schneider DJ, Avera ES, Bergmann SR, Braunwald E, Collen D, Frye R, Jaffe A, Kirk RJ, Ludbrook PA, Roberts R, Spector P, Vlasuk GP, Willerson JT. In memoriam: Burton E. Sobel a tribute from family, friends and colleagues October 21, 1937 - May 3, 2013. Exp Biol Med (Maywood). 2013 Oct; 238(10):1101-15. PMID: 24072785.
      Citations:    Fields:    
    63. Virani SS, Lee VV, Brautbar A, Grove ML, Nambi V, Alam M, Elayda M, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Single nucleotide polymorphisms in cholesteryl ester transfer protein gene and recurrent coronary heart disease or mortality in patients with established atherosclerosis. Am J Cardiol. 2013 Nov 01; 112(9):1287-92. PMID: 23891427.
      Citations:    Fields:    Translation:Humans
    64. Zhou L, Chen Z, Vanderslice P, So SP, Ruan KH, Willerson JT, Dixon RA. Endothelial-like progenitor cells engineered to produce prostacyclin rescue monocrotaline-induced pulmonary arterial hypertension and provide right ventricle benefits. Circulation. 2013 Aug 27; 128(9):982-94. PMID: 23841984.
      Citations: 15     Fields:    Translation:AnimalsCells
    65. Liu X, Terry T, Pan S, Yang Z, Willerson JT, Dixon RA, Liu Q. Osmotic drug delivery to ischemic hindlimbs and perfusion of vasculature with microfil for micro-computed tomography imaging. J Vis Exp. 2013 Jun 29; (76). PMID: 23852145.
      Citations: 5     Fields:    Translation:Animals
    66. Madonna R, Taylor DA, Geng YJ, De Caterina R, Shelat H, Perin EC, Willerson JT. Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia. Circ Res. 2013 Sep 13; 113(7):902-14. PMID: 23780385.
      Citations: 23     Fields:    Translation:AnimalsCells
    67. Vanderslice P, Biediger RJ, Woodside DG, Brown WS, Khounlo S, Warier ND, Gundlach CW, Caivano AR, Bornmann WG, Maxwell DS, McIntyre BW, Willerson JT, Dixon RA. Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion. J Biol Chem. 2013 Jul 05; 288(27):19414-28. PMID: 23703610.
      Citations: 6     Fields:    Translation:HumansCells
    68. Hare JM, Bolli R, Cooke JP, Gordon DJ, Henry TD, Perin EC, March KL, Murphy MP, Pepine CJ, Simari RD, Skarlatos SI, Traverse JH, Willerson JT, Szady AD, Taylor DA, Vojvodic RW, Yang PC, Moyé LA. Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN). Circulation. 2013 Apr 16; 127(15):1630-5. PMID: 23588961.
      Citations: 17     Fields:    Translation:Humans
    69. Liu X, Terry T, Pan S, Yang Z, Willerson JT, Dixon RA, Liu Q. Targeted delivery of carbaprostacyclin to ischemic hindlimbs enhances adaptive remodeling of the microvascular network. Hypertension. 2013 May; 61(5):1036-43. PMID: 23529172.
      Citations: 2     Fields:    Translation:AnimalsCells
    70. Bhavane R, Badea C, Ghaghada KB, Clark D, Vela D, Moturu A, Annapragada A, Johnson GA, Willerson JT, Annapragada A. Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent. Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):285-94. PMID: 23349231.
      Citations: 19     Fields:    Translation:AnimalsCells
    71. Angelini P, Vidovich MI, Lawless CE, Elayda MA, Lopez JA, Wolf D, Willerson JT. Preventing sudden cardiac death in athletes: in search of evidence-based, cost-effective screening. Tex Heart Inst J. 2013; 40(2):148-55. PMID: 23678212.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    72. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Zhao DX, Ellis SG, Forder JR, Anderson RD, Hatzopoulos AK, Penn MS, Perin EC, Chambers J, Baran KW, Raveendran G, Lambert C, Lerman A, Simon DI, Vaughan DE, Lai D, Gee AP, Taylor DA, Cogle CR, Thomas JD, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Kappenman C, Westbrook L, Piller LB, Simpson LM, Baraniuk S, Loghin C, Aguilar D, Richman S, Zierold C, Spoon DB, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA. 2012 Dec 12; 308(22):2380-9. PMID: 23129008.
      Citations: 141     Fields:    Translation:Humans
    73. Perin EC, Willerson JT. Buying new soul. J Am Coll Cardiol. 2012 Nov 20; 60(21):2250-1. PMID: 23153847.
      Citations:    Fields:    Translation:HumansAnimals
    74. Willerson JT, Yeh ET, Perin EC. Cytokine profile and ST-elevation myocardial infarction. Circ Res. 2012 Oct 26; 111(10):1256-7. PMID: 23104875.
      Citations:    Fields:    Translation:Humans
    75. Yeh ET, Willerson JT. Heparin and bone marrow-derived cell therapy: friend or foe? Circ Res. 2012 Sep 14; 111(7):819-20. PMID: 22982868.
      Citations:    Fields:    Translation:HumansAnimalsCells
    76. Madonna R, Wu D, Wassler M, De Caterina R, Willerson JT, Geng YJ. Myocardin-A enhances expression of promyogenic genes without depressing telomerase activity in adipose tissue-derived mesenchymal stem cells. Int J Cardiol. 2013 Sep 10; 167(6):2912-21. PMID: 22884695.
      Citations: 1     Fields:    Translation:AnimalsCells
    77. Haidari M, Zhang W, Caivano A, Chen Z, Ganjehei L, Mortazavi A, Stroud C, Woodside DG, Willerson JT, Dixon RA. Integrin a2ß1 mediates tyrosine phosphorylation of vascular endothelial cadherin induced by invasive breast cancer cells. J Biol Chem. 2012 Sep 21; 287(39):32981-92. PMID: 22833667.
      Citations: 20     Fields:    Translation:HumansCells
    78. Islas JF, Liu Y, Weng KC, Robertson MJ, Zhang S, Prejusa A, Harger J, Tikhomirova D, Chopra M, Iyer D, Mercola M, Oshima RG, Willerson JT, Potaman VN, Schwartz RJ. Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors. Proc Natl Acad Sci U S A. 2012 Aug 07; 109(32):13016-21. PMID: 22826236.
      Citations: 79     Fields:    Translation:HumansAnimalsCells
    79. Friedewald VE, Hare JM, Miller LW, Walpole HT, Willerson JT, Roberts WC. The editor's roundtable: advances in stem cell therapy for treatment of cardiovascular disease. Am J Cardiol. 2012 Sep 15; 110(6):807-16. PMID: 22818841.
      Citations: 1     Fields:    Translation:Humans
    80. Chen SN, Czernuszewicz G, Tan Y, Lombardi R, Jin J, Willerson JT, Marian AJ. Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy. Circ Res. 2012 Sep 14; 111(7):907-19. PMID: 22821932.
      Citations: 40     Fields:    Translation:HumansAnimalsCells
    81. Liu Q, Xi Y, Terry T, So SP, Mohite A, Zhang J, Wu G, Liu X, Cheng J, Ruan KH, Willerson JT, Dixon RA. Engineered endothelial progenitor cells that overexpress prostacyclin protect vascular cells. J Cell Physiol. 2012 Jul; 227(7):2907-16. PMID: 21938725.
      Citations: 5     Fields:    Translation:AnimalsCells
    82. Rodriguez-Porcel M, Kronenberg MW, Henry TD, Traverse JH, Pepine CJ, Ellis SG, Willerson JT, Moyé LA, Simari RD. Cell tracking and the development of cell-based therapies: a view from the Cardiovascular Cell Therapy Research Network. JACC Cardiovasc Imaging. 2012 May; 5(5):559-65. PMID: 22595165.
      Citations: 8     Fields:    Translation:HumansAnimals
    83. Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA. 2012 Apr 25; 307(16):1717-26. PMID: 22447880.
      Citations: 142     Fields:    Translation:HumansCTClinical Trials
    84. Richman S, Gee AP, McKenna DH, Traverse JH, Henry TD, Fisk D, Pepine CJ, Bloom J, Willerson JT, Prater K, Zhao D, Koç JR, Anwaruddin S, Taylor DA, Cogle CR, Moyé LA, Simari RD, Skarlatos SI. Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study. Transfusion. 2012 Oct; 52(10):2225-33. PMID: 22320233.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    85. Perin EC, Silva GV, Zheng Y, Gahremanpour A, Canales J, Patel D, Fernandes MR, Keller LH, Quan X, Coulter SA, Moore WH, Herlihy JP, Willerson JT. Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure. Am Heart J. 2012 Mar; 163(3):415-21, 421.e1. PMID: 22424012.
      Citations: 31     Fields:    Translation:HumansCTClinical Trials
    86. Virani SS, Brautbar A, Lee VV, MacArthur E, Morrison AC, Grove ML, Nambi V, Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. Circ J. 2012; 76(4):950-6. PMID: 22322877.
      Citations: 18     Fields:    Translation:HumansCells
    87. Willerson J. James Willerson: leading the Texans' fight against heart disease. Interview by Ruth Williams. Circ Res. 2012 Feb 03; 110(3):381-4. PMID: 22302753.
      Citations:    Fields:    
    88. Geng YJ, Willerson JT. Repairing the infarcted heart with stem cells from umbilical cord stroma. Cardiology. 2011; 120(2):100-2. PMID: 22179040.
      Citations:    Fields:    Translation:HumansAnimalsCells
    89. Wang J, Najjar A, Zhang S, Rabinovich B, Willerson JT, Gelovani JG, Yeh ET. Molecular imaging of mesenchymal stem cell: mechanistic insight into cardiac repair after experimental myocardial infarction. Circ Cardiovasc Imaging. 2012 Jan; 5(1):94-101. PMID: 22135400.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    90. Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Forder JR, Byrne BJ, Hatzopoulos AK, Penn MS, Perin EC, Baran KW, Chambers J, Lambert C, Raveendran G, Simon DI, Vaughan DE, Simpson LM, Gee AP, Taylor DA, Cogle CR, Thomas JD, Silva GV, Jorgenson BC, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Smith DX, Baraniuk S, Piller LB, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA. 2011 Nov 16; 306(19):2110-9. PMID: 22084195.
      Citations: 143     Fields:    Translation:Humans
    91. Lombardi R, da Graca Cabreira-Hansen M, Bell A, Fromm RR, Willerson JT, Marian AJ. Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res. 2011 Dec 09; 109(12):1342-53. PMID: 22021931.
      Citations: 58     Fields:    Translation:AnimalsCells
    92. Madjid M, Willerson JT. Inflammatory markers in coronary heart disease. Br Med Bull. 2011; 100:23-38. PMID: 22010105.
      Citations: 27     Fields:    Translation:Humans
    93. Perin EC, Tian M, Marini FC, Silva GV, Zheng Y, Baimbridge F, Quan X, Fernandes MR, Gahremanpour A, Young D, Paolillo V, Mukhopadhyay U, Borne AT, Uthamanthil R, Brammer D, Jackson J, Decker WK, Najjar AM, Thomas MW, Volgin A, Rabinovich B, Soghomonyan S, Jeong HJ, Rios JM, Steiner D, Robinson S, Mawlawi O, Pan T, Stafford J, Kundra V, Li C, Alauddin MM, Willerson JT, Shpall E, Gelovani JG. Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model. PLoS One. 2011; 6(9):e22949. PMID: 21912635.
      Citations: 18     Fields:    Translation:AnimalsCells
    94. Perin EC, Willerson JT. CD34+ autologous human stem cells in treating refractory angina. Circ Res. 2011 Aug 05; 109(4):351-2. PMID: 21817161.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    95. Gundlach CW, Caivano A, Cabreira-Hansen Mda G, Gahremanpour A, Brown WS, Zheng Y, McIntyre BW, Willerson JT, Dixon RA, Perin EC, Woodside DG. Synthesis and evaluation of an anti-MLC1 × anti-CD90 bispecific antibody for targeting and retaining bone-marrow-derived multipotent stromal cells in infarcted myocardium. Bioconjug Chem. 2011 Aug 17; 22(8):1706-14. PMID: 21749133.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    96. Murrow J, Esteves F, Galt J, Chen J, Garcia E, Lin J, Lerakis S, Sher S, Khan Pohlel F, Waller EK, Vaughan D, Perin E, Willerson J, Kereiakes D, Preti R, Pecora AL, Quyyumi AA. Characterization of mechanical dyssynchrony measured by gated single photon emission computed tomography phase analysis after acute ST-elevation myocardial infarction. J Nucl Cardiol. 2011 Oct; 18(5):912-9. PMID: 21717276.
      Citations: 4     Fields:    Translation:Humans
    97. Rodriguez G, Ueyama T, Ogata T, Czernuszewicz G, Tan Y, Dorn GW, Bogaev R, Amano K, Oh H, Matsubara H, Willerson JT, Marian AJ. Molecular genetic and functional characterization implicate muscle-restricted coiled-coil gene (MURC) as a causal gene for familial dilated cardiomyopathy. Circ Cardiovasc Genet. 2011 Aug 01; 4(4):349-58. PMID: 21642240.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    98. Terry T, Chen Z, Dixon RA, Vanderslice P, Zoldhelyi P, Willerson JT, Liu Q. CD34?/M-cadherin? bone marrow progenitor cells promote arteriogenesis in ischemic hindlimbs of ApoE?/? mice. PLoS One. 2011; 6(6):e20673. PMID: 21677770.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    99. Rodriguez G, Starr AZ, Czernuszewicz GZ, Manhas A, Alhariri A, Willerson JT, Reist CJ, Pieper K, Mahaffey KW, Marian AJ, Kleiman NS. Determinants of plasma vitamin D levels in patients with acute coronary syndromes. Eur J Clin Invest. 2011 Dec; 41(12):1299-309. PMID: 21615392.
      Citations: 3     Fields:    Translation:Humans
    100. Perin EC, Silva G, Gahremanpour A, Canales J, Zheng Y, Cabreira-Hansen MG, Mendelsohn F, Chronos N, Haley R, Willerson JT, Annex BH. A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2011 Dec 01; 78(7):1060-7. PMID: 21594960.
      Citations: 19     Fields:    Translation:HumansCellsCTClinical Trials
    101. Perin EC, Silva GV, Henry TD, Cabreira-Hansen MG, Moore WH, Coulter SA, Herlihy JP, Fernandes MR, Cheong BY, Flamm SD, Traverse JH, Zheng Y, Smith D, Shaw S, Westbrook L, Olson R, Patel D, Gahremanpour A, Canales J, Vaughn WK, Willerson JT. A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J. 2011 Jun; 161(6):1078-87.e3. PMID: 21641354.
      Citations: 52     Fields:    Translation:HumansCells
    102. Virani SS, Brautbar A, Lee VV, Elayda M, Sami S, Nambi V, Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2011 May 15; 107(10):1504-9. PMID: 21414601.
      Citations: 16     Fields:    Translation:HumansCells
    103. Willerson JT. Imaging in electrical cardiac devices. J Am Coll Cardiol. 2011 Feb 15; 57(7):829-30. PMID: 21310319.
      Citations:    Fields:    Translation:Humans
    104. Silva GV, Fernandes MR, Cardoso CO, Sanz RR, Oliveira EM, Jimenez-Quevedo P, Lopez J, Angeli FS, Zheng Y, Willerson JT, Perin EC. A dosing study of bone marrow mononuclear cells for transendocardial injection in a pig model of chronic ischemic heart disease. Tex Heart Inst J. 2011; 38(3):219-24. PMID: 21720456.
      Citations: 2     Fields:    Translation:Animals
    105. Quyyumi AA, Waller EK, Murrow J, Esteves F, Galt J, Oshinski J, Lerakis S, Sher S, Vaughan D, Perin E, Willerson J, Kereiakes D, Gersh BJ, Gregory D, Werner A, Moss T, Chan WS, Preti R, Pecora AL. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am Heart J. 2011 Jan; 161(1):98-105. PMID: 21167340.
      Citations: 53     Fields:    Translation:HumansCells
    106. Aboshady I, Cody DD, Johnson EM, Gahremanpour A, Vela D, Khalil KG, Dupont HL, Willerson JT, Buja LM, Gladish GW. Flat-panel versus 64-channel computed tomography for in vivo quantitative characterization of aortic atherosclerotic plaques. Int J Cardiol. 2012 May 03; 156(3):295-302. PMID: 21185613.
      Citations:    Fields:    Translation:Animals
    107. Madonna R, De Caterina R, Willerson JT, Geng YJ. Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration. Eur Heart J. 2011 May; 32(10):1190-6. PMID: 21148539.
      Citations: 12     Fields:    Translation:HumansCells
    108. Tran LA, Krishnamurthy R, Muthupillai R, Cabreira-Hansen Mda G, Willerson JT, Perin EC, Wilson LJ. Gadonanotubes as magnetic nanolabels for stem cell detection. Biomaterials. 2010 Dec; 31(36):9482-91. PMID: 20965562.
      Citations: 22     Fields:    Translation:AnimalsCells
    109. Gee AP, Richman S, Durett A, McKenna D, Traverse J, Henry T, Fisk D, Pepine C, Bloom J, Willerson J, Prater K, Zhao D, Koç JR, Ellis S, Taylor D, Cogle C, Moyé L, Simari R, Skarlatos S. Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience. Cytotherapy. 2010 Sep; 12(5):684-91. PMID: 20524773.
      Citations: 19     Fields:    Translation:HumansCellsCTClinical Trials
    110. Perin EC, Silva GV, Willerson JT. Training on the use of transendocardial delivery of biologics for cardiac regeneration. JACC Cardiovasc Interv. 2010 Sep; 3(9):991. PMID: 20850103.
      Citations:    Fields:    Translation:HumansAnimals
    111. Nagueh SF, Lombardi R, Tan Y, Wang J, Willerson JT, Marian AJ. Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study. Eur J Clin Invest. 2010 Nov; 40(11):976-83. PMID: 20629707.
      Citations: 12     Fields:    Translation:Humans
    112. Willerson JT, Perin EC, Ellis SG, Pepine CJ, Henry TD, Zhao DX, Lai D, Penn MS, Byrne BJ, Silva G, Gee A, Traverse JH, Hatzopoulos AK, Forder JR, Martin D, Kronenberg M, Taylor DA, Cogle CR, Baraniuk S, Westbrook L, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moyé LA, Simari RD. Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design. Am Heart J. 2010 Aug; 160(2):215-23. PMID: 20691824.
      Citations: 21     Fields:    Translation:HumansCellsCTClinical Trials
    113. Wang J, Zhang S, Rabinovich B, Bidaut L, Soghomonyan S, Alauddin MM, Bankson JA, Shpall E, Willerson JT, Gelovani JG, Yeh ET. Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res. 2010 Jun 25; 106(12):1904-11. PMID: 20448213.
      Citations: 40     Fields:    Translation:HumansAnimalsCells
    114. Smith NL, Felix JF, Morrison AC, Demissie S, Glazer NL, Loehr LR, Cupples LA, Dehghan A, Lumley T, Rosamond WD, Lieb W, Rivadeneira F, Bis JC, Folsom AR, Benjamin E, Aulchenko YS, Haritunians T, Couper D, Murabito J, Wang YA, Stricker BH, Gottdiener JS, Chang PP, Wang TJ, Rice KM, Hofman A, Heckbert SR, Fox ER, O'Donnell CJ, Uitterlinden AG, Rotter JI, Willerson JT, Levy D, van Duijn CM, Psaty BM, Witteman JC, Boerwinkle E, Vasan RS. Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Circ Cardiovasc Genet. 2010 Jun; 3(3):256-66. PMID: 20445134.
      Citations: 70     Fields:    Translation:Humans
    115. Kohsaka S, Kimura T, Goto M, Lee VV, Elayda M, Furukawa Y, Fukushima M, Komeda M, Sakata R, Willerson JT, Wilson JM, Kita T. Difference in patient profiles and outcomes in Japanese versus American patients undergoing coronary revascularization (collaborative study by CREDO-Kyoto and the Texas Heart Institute Research Database). Am J Cardiol. 2010 Jun 15; 105(12):1698-704. PMID: 20538117.
      Citations: 10     Fields:    Translation:Humans
    116. Morrison AC, Felix JF, Cupples LA, Glazer NL, Loehr LR, Dehghan A, Demissie S, Bis JC, Rosamond WD, Aulchenko YS, Wang YA, Haritunians T, Folsom AR, Rivadeneira F, Benjamin EJ, Lumley T, Couper D, Stricker BH, O'Donnell CJ, Rice KM, Chang PP, Hofman A, Levy D, Rotter JI, Fox ER, Uitterlinden AG, Wang TJ, Psaty BM, Willerson JT, van Duijn CM, Boerwinkle E, Witteman JC, Vasan RS, Smith NL. Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium. Circ Cardiovasc Genet. 2010 Jun; 3(3):248-55. PMID: 20400778.
      Citations: 29     Fields:    Translation:Humans
    117. Virani SS, Nambi V, Polsani VR, Lee VV, Elayda M, Kohsaka S, Pan W, Reul RM, Wilson JM, Petersen LA, Willerson JT, Ballantyne CM. Preoperative statin therapy decreases risk of postoperative renal insufficiency. Cardiovasc Ther. 2010 Apr; 28(2):80-6. PMID: 20398096.
      Citations: 14     Fields:    Translation:Humans
    118. El-Hamamsy I, Willerson JT, Yacoub MH. Preserved homograft function 32 years after surgery in a young patient. J Thorac Cardiovasc Surg. 2010 Jun; 139(6):e141-2. PMID: 20338596.
      Citations: 1     Fields:    Translation:Humans
    119. Simari RD, Moyé LA, Skarlatos SI, Ellis SG, Zhao DX, Willerson JT, Henry TD, Pepine CJ. Development of a network to test strategies in cardiovascular cell delivery: the NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN). J Cardiovasc Transl Res. 2010 Feb; 3(1):30-6. PMID: 20445812.
      Citations: 24     Fields:    Translation:Humans
    120. Friedewald VE, Cohn LH, Kelly JP, Roberts R, Wesson DE, Willerson JT, Yancy CW, Roberts WC. The Editor's Roundtable: Health reform and its implications for cardiovascular medicine. Am J Cardiol. 2010 Feb 15; 105(4):557-65. PMID: 20152254.
      Citations:    Fields:    Translation:Humans
    121. Sami S, Willerson JT. Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2). Tex Heart Inst J. 2010; 37(3):262-75. PMID: 20548800.
      Citations: 4     Fields:    Translation:Humans
    122. Ruan CH, Dixon RA, Willerson JT, Ruan KH. Prostacyclin therapy for pulmonary arterial hypertension. Tex Heart Inst J. 2010; 37(4):391-9. PMID: 20844610.
      Citations: 12     Fields:    Translation:HumansCells
    123. Willerson JT. Texas Heart Institute Medal and The Ray C. Fish Award for Scientific Achievement in Cardiovascular Diseases. Tex Heart Inst J. 2010; 37(1):1-2. PMID: 20200620.
      Citations:    Fields:    Translation:Humans
    124. Madjid M, Ali M, Willerson JT. Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature. Tex Heart Inst J. 2010; 37(1):25-39. PMID: 20200624.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    125. Traverse JH, Henry TD, Vaughan DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Simpson LM, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, Taylor DA, Cogle CR, Baraniuk S, Olson RE, Jorgenson BC, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moyè LA, Simari RD. LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction. Tex Heart Inst J. 2010; 37(4):412-20. PMID: 20844613.
      Citations: 29     Fields:    Translation:HumansCTClinical Trials
    126. Sami S, Willerson JT. Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 1). Tex Heart Inst J. 2010; 37(2):141-8. PMID: 20401284.
      Citations: 1     Fields:    Translation:Humans
    127. Chen SN, Cilingiroglu M, Todd J, Lombardi R, Willerson JT, Gotto AM, Ballantyne CM, Marian AJ. Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis. BMC Med Genet. 2009 Oct 30; 10:111. PMID: 19878569.
      Citations: 25     Fields:    Translation:Humans
    128. Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER). Circ Cardiovasc Qual Outcomes. 2009 Nov; 2(6):616-23. PMID: 20031900.
      Citations: 31     Fields:    Translation:HumansPHPublic Health
    129. Yang YJ, Qian HY, Huang J, Li JJ, Gao RL, Dou KF, Yang GS, Willerson JT, Geng YJ. Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol. 2009 Dec; 29(12):2076-82. PMID: 19762786.
      Citations: 42     Fields:    Translation:AnimalsCells
    130. Traverse JH, Henry TD, Vaughan DE, Vaughn DE, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Piller LB, Penn MS, Byrne BJ, Perin EC, Gee AP, Hatzopoulos AK, McKenna DH, Forder JR, Taylor DA, Cogle CR, Olson RE, Jorgenson BC, Sayre SL, Vojvodic RW, Gordon DJ, Skarlatos SI, Moye' LA, Simari RD. Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction. Am Heart J. 2009 Sep; 158(3):356-63. PMID: 19699857.
      Citations: 41     Fields:    Translation:HumansCellsCTClinical Trials
    131. Liu Q, Chen Z, Terry T, McNatt JM, Willerson JT, Zoldhelyi P. Intra-arterial transplantation of adult bone marrow cells restores blood flow and regenerates skeletal muscle in ischemic limbs. Vasc Endovascular Surg. 2009 Oct-Nov; 43(5):433-43. PMID: 19628514.
      Citations: 8     Fields:    Translation:AnimalsCells
    132. Madonna R, Shelat H, Xue Q, Willerson JT, De Caterina R, Geng YJ. Erythropoietin protects myocardin-expressing cardiac stem cells against cytotoxicity of tumor necrosis factor-alpha. Exp Cell Res. 2009 Oct 15; 315(17):2921-8. PMID: 19631208.
      Citations: 4     Fields:    Translation:AnimalsCells
    133. Willerson JT. Myocardial perfusion scintigraphy and value in patients with non-ST segment elevation acute coronary syndromes. Am J Cardiol. 2009 Sep 01; 104(5):738. PMID: 19699355.
      Citations:    Fields:    Translation:Humans
    134. Ridker PM, Friedewald VE, Davidson MH, Willerson JT, Roberts WC. The editor's roundtable: the JUPITER trial--initial results and clinical implications. Am J Cardiol. 2009 May 15; 103(10):1417-25. PMID: 19427439.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    135. Chen CH, Dixon RA, Ke LY, Willerson JT. Vascular progenitor cells in diabetes mellitus: roles of Wnt signaling and negatively charged low-density lipoprotein. Circ Res. 2009 May 08; 104(9):1038-40. PMID: 19423862.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    136. Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, Kim DH, Pannu H, Willing MC, Sparks E, Pyeritz RE, Singh MN, Dalman RL, Grotta JC, Marian AJ, Boerwinkle EA, Frazier LQ, LeMaire SA, Coselli JS, Estrera AL, Safi HJ, Veeraraghavan S, Muzny DM, Wheeler DA, Willerson JT, Yu RK, Shete SS, Scherer SE, Raman CS, Buja LM, Milewicz DM. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009 May; 84(5):617-27. PMID: 19409525.
      Citations: 133     Fields:    Translation:HumansCells
    137. Brautbar A, Ballantyne CM, Lawson K, Nambi V, Chambless L, Folsom AR, Willerson JT, Boerwinkle E. Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study. Circ Cardiovasc Genet. 2009 Jun; 2(3):279-85. PMID: 20031596.
      Citations: 44     Fields:    Translation:HumansCells
    138. Lombardi R, Dong J, Rodriguez G, Bell A, Leung TK, Schwartz RJ, Willerson JT, Brugada R, Marian AJ. Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res. 2009 May 08; 104(9):1076-84. PMID: 19359597.
      Citations: 54     Fields:    Translation:HumansAnimalsCells
    139. Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Ridker PM. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med. 2009 Apr 30; 360(18):1851-61. PMID: 19329822.
      Citations: 149     Fields:    Translation:Humans
    140. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet. 2009 Apr 04; 373(9670):1175-82. PMID: 19329177.
      Citations: 234     Fields:    Translation:Humans
    141. Lombardi R, Rodriguez G, Chen SN, Ripplinger CM, Li W, Chen J, Willerson JT, Betocchi S, Wickline SA, Efimov IR, Marian AJ. Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms. Circulation. 2009 Mar 17; 119(10):1398-407. PMID: 19255346.
      Citations: 44     Fields:    Translation:HumansAnimalsCells
    142. Frazier L, Vaughn WK, Willerson JT, Ballantyne CM, Boerwinkle E. Inflammatory protein levels and depression screening after coronary stenting predict major adverse coronary events. Biol Res Nurs. 2009 Oct; 11(2):163-73. PMID: 19251718.
      Citations: 3     Fields:    Translation:Humans
    143. Eichstaedt HC, Liu Q, Chen Z, Bobustuc GC, Terry T, Willerson JT, Zoldhelyi P. Gene transfer of COX-1 improves lumen size and blood flow in carotid bypass grafts. J Surg Res. 2010 Jun 01; 161(1):162-7. PMID: 19361808.
      Citations: 3     Fields:    Translation:Animals
    144. Willerson JT, Cable G, Yeh ET. PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin. Tex Heart Inst J. 2009; 36(6):530-9. PMID: 20069077.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    145. Virani SS, Nambi V, Lee VV, Elayda MA, Pan W, Petersen LA, Wilson JM, Willerson JT, Ballantyne CM. Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery? Tex Heart Inst J. 2009; 36(6):540-5. PMID: 20069078.
      Citations: 3     Fields:    Translation:Humans
    146. Friedewald VE, Ambrose JA, Stone GW, Roberts WC, Willerson JT. The editor's roundtable: the vulnerable plaque. Am J Cardiol. 2008 Dec 15; 102(12):1644-53. PMID: 19064018.
      Citations: 2     Fields:    Translation:Humans
    147. Vela DC, Silva GV, Assad JA, Sousa AL, Coulter S, Fernandes MR, Perin EC, Willerson JT, Buja LM. Histopathological study of healing after allogenic mesenchymal stem cell delivery in myocardial infarction in dogs. J Histochem Cytochem. 2009 Feb; 57(2):167-76. PMID: 19001635.
      Citations: 14     Fields:    Translation:AnimalsCells
    148. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008 Nov 20; 359(21):2195-207. PMID: 18997196.
      Citations: 1428     Fields:    Translation:Humans
    149. Morrison AC, Bare LA, Luke MM, Pankow JS, Mosley TH, Devlin JJ, Willerson JT, Boerwinkle E. Single nucleotide polymorphisms associated with coronary heart disease predict incident ischemic stroke in the atherosclerosis risk in communities study. Cerebrovasc Dis. 2008; 26(4):420-4. PMID: 18799872.
      Citations: 5     Fields:    Translation:Humans
    150. Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, Davidson MH, Mora S. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008 Oct; 5(10):621-35. PMID: 18711404.
      Citations: 31     Fields:    Translation:HumansPHPublic Health
    151. Jiménez-Quevedo P, Silva GV, Sanz-Ruiz R, Oliveira EM, Fernandes MR, Angeli F, Willerson JT, Dohmann HF, Perin EC. [Diabetic and nondiabetic patients respond differently to transendocardial injection of bone marrow mononuclear cells: findings from prospective clinical trials in "no-option" patients]. Rev Esp Cardiol. 2008 Jun; 61(6):635-9. PMID: 18570786.
      Citations: 7     Fields:    Translation:HumansCells
    152. Willerson JT. Passing of the editorship to Dr. James Willerson. Tex Heart Inst J. 2008; 35(1):2. PMID: 18427642.
      Citations:    Fields:    Translation:Humans
    153. Gertz SD, Bodmann BG, Vela D, Papadakis M, Aboshady I, Cherukuri P, Alexander S, Kouri DJ, Baid S, Gittens AA, Gladish GW, Conyers JL, Cody DD, Gavish L, Mazraeshahi RM, Wilner WT, Frazier L, Madjid M, Zarrabi A, Lukovenkov S, Ahmed A, Willerson JT, Casscells SW. Three-dimensional isotropic wavelets for post-acquisitional extraction of latent images of atherosclerotic plaque components from micro-computed tomography of human coronary arteries. Acad Radiol. 2007 Dec; 14(12):1509-19. PMID: 18035280.
      Citations: 1     Fields:    Translation:Humans
    154. Wilner WT, Mazraeshahi RM, Aboshady I, Bodmann BG, Papadakis M, Kouri D, Conyers JL, Cherukuri P, Vela D, Gladish G, Gavish L, Cody DD, Frazier L, Lukovenkov S, Madjid M, Zarrabi A, Ahmed A, Willerson JT, Casscells SW, Gertz SD. Quantification of roughness of calcific deposits in computed tomography scans of human coronary arteries. Invest Radiol. 2007 Nov; 42(11):771-6. PMID: 18030200.
      Citations: 1     Fields:    Translation:Humans
    155. Ridker PM, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, Khurmi NS, Koenig W, Libby P, Lorenzatti AJ, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. Am J Cardiol. 2007 Dec 01; 100(11):1659-64. PMID: 18036365.
      Citations: 24     Fields:    Translation:HumansPHPublic Health
    156. Madonna R, Willerson JT, Geng YJ. Myocardin a enhances telomerase activities in adipose tissue mesenchymal cells and embryonic stem cells undergoing cardiovascular myogenic differentiation. Stem Cells. 2008 Jan; 26(1):202-11. PMID: 17916802.
      Citations: 14     Fields:    Translation:AnimalsCells
    157. Perin EC, Silva GV, Assad JA, Vela D, Buja LM, Sousa AL, Litovsky S, Lin J, Vaughn WK, Coulter S, Fernandes MR, Willerson JT. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol. 2008 Mar; 44(3):486-95. PMID: 18061611.
      Citations: 81     Fields:    Translation:AnimalsCells
    158. Bare LA, Morrison AC, Rowland CM, Shiffman D, Luke MM, Iakoubova OA, Kane JP, Malloy MJ, Ellis SG, Pankow JS, Willerson JT, Devlin JJ, Boerwinkle E. Five common gene variants identify elevated genetic risk for coronary heart disease. Genet Med. 2007 Oct; 9(10):682-9. PMID: 18073581.
      Citations: 40     Fields:    Translation:Humans
    159. Morrison AC, Bare LA, Chambless LE, Ellis SG, Malloy M, Kane JP, Pankow JS, Devlin JJ, Willerson JT, Boerwinkle E. Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2007 Jul 01; 166(1):28-35. PMID: 17443022.
      Citations: 105     Fields:    Translation:Humans
    160. Madjid M, Toutouzas K, Stefanadis C, Willerson JT, Casscells SW. Coronary thermography for detection of vulnerable plaques. J Nucl Cardiol. 2007 Apr; 14(2):244-9. PMID: 17386387.
      Citations: 1     Fields:    Translation:HumansAnimals
    161. Kohsaka S, Volcik KA, Folsom AR, Wu KK, Ballantyne CM, Willerson JT, Boerwinkle E. Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G-765C polymorphism in African-Americans: the Atherosclerosis Risk in Communities Study. Atherosclerosis. 2008 Feb; 196(2):926-30. PMID: 17350020.
      Citations: 18     Fields:    Translation:Humans
    162. Osio A, Tan L, Chen SN, Lombardi R, Nagueh SF, Shete S, Roberts R, Willerson JT, Marian AJ. Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ Res. 2007 Mar 30; 100(6):766-8. PMID: 17347475.
      Citations: 64     Fields:    Translation:HumansCells
    163. Vela D, Buja LM, Madjid M, Burke A, Naghavi M, Willerson JT, Casscells SW, Litovsky S. The role of periadventitial fat in atherosclerosis. Arch Pathol Lab Med. 2007 Mar; 131(3):481-7. PMID: 17516753.
      Citations: 27     Fields:    Translation:HumansAnimals
    164. Zhang S, Shpall E, Willerson JT, Yeh ET. Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction. Circ Res. 2007 Mar 16; 100(5):693-702. PMID: 17303762.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    165. Geng YJ, Yang YJ, Casscells SW, Willerson JT. Vascular stem cells: a new concept in the pathogenesis of atherosclerosis and interventions for coronary heart disease. Future Cardiol. 2006 Sep; 2(5):585-92. PMID: 19804196.
      Citations: 1     Fields:    
    166. Assali AR, Moustapha A, Sdringola S, Denktas AE, Willerson JT, Holmes DR, Smalling RW. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial). Am J Cardiol. 2006 Sep 15; 98(6):729-33. PMID: 16950172.
      Citations: 4     Fields:    Translation:Humans
    167. Garcia-Gras E, Lombardi R, Giocondo MJ, Willerson JT, Schneider MD, Khoury DS, Marian AJ. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest. 2006 Jul; 116(7):2012-21. PMID: 16823493.
      Citations: 193     Fields:    Translation:HumansAnimalsCells
    168. Tsimikas S, Willerson JT, Ridker PM. C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol. 2006 Apr 18; 47(8 Suppl):C19-31. PMID: 16631506.
      Citations: 72     Fields:    Translation:Humans
    169. Madjid M, Willerson JT, Casscells SW. Intracoronary thermography for detection of high-risk vulnerable plaques. J Am Coll Cardiol. 2006 Apr 18; 47(8 Suppl):C80-5. PMID: 16631514.
      Citations: 10     Fields:    Translation:HumansAnimals
    170. Singh M, Williams BA, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Cutlip DE, Holmes DR. Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial. J Am Coll Cardiol. 2006 Jan 03; 47(1):34-9. PMID: 16386661.
      Citations: 4     Fields:    Translation:Humans
    171. Gertz SD, Cherukuri P, Bodmann BG, Gladish G, Wilner WT, Conyers JL, Aboshady I, Madjid M, Vela D, Lukovenkov S, Papadakis M, Kouri D, Mazraeshahi RM, Frazier L, Zarrabi A, Elrod D, Willerson JT, Casscells SW. Usefulness of multidetector computed tomography for noninvasive evaluation of coronary arteries in asymptomatic patients. Am J Cardiol. 2006 Jan 15; 97(2):287-93. PMID: 16442381.
      Citations: 2     Fields:    Translation:Humans
    172. Willerson JT, Yeh ET, Geng YJ, Perin EC. Blood-derived progenitor cells after recanalization of chronic coronary artery occlusions in humans. Circ Res. 2005 Oct 14; 97(8):735-6. PMID: 16224072.
      Citations:    Fields:    Translation:Humans
    173. Calabro P, Chang DW, Willerson JT, Yeh ET. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. J Am Coll Cardiol. 2005 Sep 20; 46(6):1112-3. PMID: 16168299.
      Citations: 67     Fields:    Translation:HumansCells
    174. Arjomand H, Willerson JT, Holmes DR, Bamlet WR, Surabhi SK, Roukoz B, Espinoza A, McClelland RL, McCormick DJ, Goldberg S. Outcome of patients with prior percutaneous revascularization undergoing repeat coronary intervention (from the PRESTO Trial). Am J Cardiol. 2005 Sep 15; 96(6):741-6. PMID: 16169350.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    175. Calabrò P, Samudio I, Safe SH, Willerson JT, Yeh ET. Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects. J Vasc Res. 2005 Nov-Dec; 42(6):509-16. PMID: 16155367.
      Citations: 6     Fields:    Translation:HumansCells
    176. Garot P, Lefèvre T, Savage M, Louvard Y, Bamlet WR, Willerson JT, Morice MC, Holmes DR. Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. J Am Coll Cardiol. 2005 Aug 16; 46(4):606-12. PMID: 16098423.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    177. Dohmann HF, Perin EC, Takiya CM, Silva GV, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Pascarelli BM, Assis IM, Dutra HS, Assad JA, Castello-Branco RV, Drummond C, Dohmann HJ, Willerson JT, Borojevic R. Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation. 2005 Jul 26; 112(4):521-6. PMID: 16027258.
      Citations: 24     Fields:    Translation:HumansCells
    178. Senthil V, Chen SN, Tsybouleva N, Halder T, Nagueh SF, Willerson JT, Roberts R, Marian AJ. Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circ Res. 2005 Aug 05; 97(3):285-92. PMID: 16020756.
      Citations: 45     Fields:    Translation:AnimalsCells
    179. Chen SN, Ballantyne CM, Gotto AM, Tan Y, Willerson JT, Marian AJ. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. J Am Coll Cardiol. 2005 May 17; 45(10):1611-9. PMID: 15893176.
      Citations: 45     Fields:    Translation:HumansCTClinical Trials
    180. Liu Q, Chen ZQ, Bobustuc GC, McNatt JM, Segall H, Pan S, Willerson JT, Zoldhelyi P. Local gene transduction of cyclooxygenase-1 increases blood flow in injured atherosclerotic rabbit arteries. Circulation. 2005 Apr 12; 111(14):1833-40. PMID: 15824211.
      Citations: 3     Fields:    Translation:AnimalsCells
    181. Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Holmes DR. Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. J Am Coll Cardiol. 2005 Jan 18; 45(2):198-203. PMID: 15653015.
      Citations: 7     Fields:    Translation:Humans
    182. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ, Willerson JT, Perin EC. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation. 2005 Jan 18; 111(2):150-6. PMID: 15642764.
      Citations: 225     Fields:    Translation:AnimalsCells
    183. Zhang S, Wang D, Estrov Z, Raj S, Willerson JT, Yeh ET. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation. 2004 Dec 21; 110(25):3803-7. PMID: 15596566.
      Citations: 48     Fields:    Translation:HumansAnimalsCells
    184. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol. 2004 Nov 16; 44(10):1945-56. PMID: 15542275.
      Citations: 137     Fields:    Translation:HumansCells
    185. Calabro P, Samudio I, Willerson JT, Yeh ET. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation. 2004 Nov 23; 110(21):3335-40. PMID: 15545519.
      Citations: 67     Fields:    Translation:Cells
    186. Best PJ, Berger PB, Davis BR, Grines CL, Sadeghi HM, Williams BA, Willerson JT, Granett JR, Holmes DR. Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial. J Am Coll Cardiol. 2004 Nov 02; 44(9):1786-91. PMID: 15519008.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    187. Popp RJ, Smith SC, Adams RJ, Antman EM, Kavey RE, DeMaria AN, Ohman EM, Pitt B, Willerson JT, Bellande BJ, Fonarow GC, Nishimura RA, Shah PM, Hirshfeld JW, Messer JV, Peterson ED, Prystowsky EN, Anderson JL, Cheitlin MD, Goldstein LB, Grant AO, Beller GA, Hines EF, Livingston DW, McEntree CW. ACCF/AHA consensus conference report on professionalism and ethics. Circulation. 2004 Oct 19; 110(16):2506-49. PMID: 15492331.
      Citations: 3     Fields:    Translation:Humans
    188. Califf RM, Nissen SE, DeMaria AN, Ohman EM, Pitt B, Willerson JT, Bilheimer DW, Cohn JN, Feigal DW, Hampson L, Lorell BH, Pepine CJ, Popp RL. Task force 2: Investigator participation in clinical research. J Am Coll Cardiol. 2004 Oct 19; 44(8):1729-36. PMID: 15489116.
      Citations:    Fields:    Translation:Humans
    189. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Silva GV, Mesquita CT, Belém L, Vaughn WK, Rangel FO, Assad JA, Carvalho AC, Branco RV, Rossi MI, Dohmann HJ, Willerson JT. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation. 2004 Sep 14; 110(11 Suppl 1):II213-8. PMID: 15364865.
      Citations: 90     Fields:    Translation:HumansCellsCTClinical Trials
    190. Orford JL, Denktas AE, Williams BA, Fasseas P, Willerson JT, Berger PB, Holmes DR. Routine intravascular ultrasound scanning guidance of coronary stenting is not associated with improved clinical outcomes. Am Heart J. 2004 Sep; 148(3):501-6. PMID: 15389239.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    191. Madjid M, Zarrabi A, Litovsky S, Willerson JT, Casscells W. Finding vulnerable atherosclerotic plaques: is it worth the effort? Arterioscler Thromb Vasc Biol. 2004 Oct; 24(10):1775-82. PMID: 15308556.
      Citations: 15     Fields:    Translation:HumansAnimals
    192. Libby P, Willerson JT, Braunwald E. C-reactive protein and coronary heart disease. N Engl J Med. 2004 Jul 15; 351(3):295-8; author reply 295-8. PMID: 15257564.
      Citations: 8     Fields:    Translation:Humans
    193. Kereiakes DJ, Willerson JT. Medical technology development and approval: the future is now. Circulation. 2004 Jun 29; 109(25):3078-80. PMID: 15226223.
      Citations:    Fields:    Translation:HumansPHPublic Health
    194. Kereiakes DJ, Willerson JT. Health care on trial: America's medical malpractice crisis. Circulation. 2004 Jun 22; 109(24):2939-41. PMID: 15210609.
      Citations:    Fields:    Translation:Humans
    195. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004 Jun 01; 109(21 Suppl 1):II2-10. PMID: 15173056.
      Citations: 241     Fields:    Translation:Humans
    196. Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Holmes DR. Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial. Circulation. 2004 Jun 08; 109(22):2727-31. PMID: 15173022.
      Citations: 11     Fields:    Translation:Humans
    197. Kereiakes DJ, Willerson JT. Doctors and hospitals: healthcare's Rubik's cube. Circulation. 2004 May 25; 109(20):2381-5. PMID: 15159328.
      Citations: 1     Fields:    Translation:Humans
    198. Kereiakes DJ, Willerson JT. US health care: entitlement or privilege? Circulation. 2004 Mar 30; 109(12):1460-2. PMID: 15051650.
      Citations:    Fields:    Translation:Humans
    199. Delgado RM, Nawar MA, Zewail AM, Kar B, Vaughn WK, Wu KK, Aleksic N, Sivasubramanian N, McKay K, Mann DL, Willerson JT. Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure. Circulation. 2004 Mar 23; 109(11):1428-33. PMID: 15023870.
      Citations: 22     Fields:    Translation:Animals
    200. Kereiakes DJ, Willerson JT. The United States cardiovascular care deficit. Circulation. 2004 Feb 24; 109(7):821-3. PMID: 14981013.
      Citations: 1     Fields:    Translation:Humans
    201. White HD, Willerson JT. We must use the knowledge that we have to treat patients with acute coronary syndromes. Circulation. 2004 Feb 17; 109(6):698-700. PMID: 14970103.
      Citations: 2     Fields:    Translation:Humans
    202. Willerson JT, Kereiakes DJ. Cardiac resynchronization therapy: helpful now in selected patients with CHF. Circulation. 2004 Jan 27; 109(3):308-9. PMID: 14744955.
      Citations: 2     Fields:    Translation:Humans
    203. Mathew V, Gersh BJ, Williams BA, Laskey WK, Willerson JT, Tilbury RT, Davis BR, Holmes DR. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation. 2004 Feb 03; 109(4):476-80. PMID: 14732749.
      Citations: 51     Fields:    Translation:HumansCTClinical Trials
    204. Willerson JT. The great enemy--infectious disease. Tex Heart Inst J. 2004; 31(1):1. PMID: 15061619.
      Citations:    Fields:    Translation:HumansPHPublic Health
    205. Silva GV, Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Assad JA, Vaughn WK, Mesquita CT, Belém L, Carvalho AC, Dohmann HJ, Barroso do Amaral E, Coutinho J, Branco R, Oliveira E, Willerson JT. Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation. Tex Heart Inst J. 2004; 31(3):214-9. PMID: 15562839.
      Citations: 20     Fields:    Translation:HumansCellsCTClinical Trials
    206. Willerson JT, Kereiakes DJ. Editors' commentary: mechanical circulatory support. Circulation. 2003 Dec 23; 108(25):3069-70. PMID: 14691021.
      Citations:    Fields:    Translation:Humans
    207. Kereiakes DJ, Willerson JT. Therapeutic substitution: guilty until proven innocent. Circulation. 2003 Nov 25; 108(21):2611-2. PMID: 14638525.
      Citations: 4     Fields:    Translation:Humans
    208. Willerson JT, Kereiakes DJ. Endothelial dysfunction. Circulation. 2003 Oct 28; 108(17):2060-1. PMID: 14581385.
      Citations: 6     Fields:    Translation:Humans
    209. Yeh ET, Zhang S, Wu HD, Körbling M, Willerson JT, Estrov Z. Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation. 2003 Oct 28; 108(17):2070-3. PMID: 14568894.
      Citations: 102     Fields:    Translation:HumansAnimalsCells
    210. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation. 2003 Oct 14; 108(15):1772-8. PMID: 14557340.
      Citations: 249     Fields:    Translation:HumansAnimalsPHPublic Health
    211. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003 Oct 07; 108(14):1664-72. PMID: 14530185.
      Citations: 522     Fields:    Translation:Humans
    212. Calabró P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation. 2003 Oct 21; 108(16):1930-2. PMID: 14530191.
      Citations: 95     Fields:    Translation:HumansCells
    213. Kereiakes DJ, Willerson JT. Metabolic syndrome epidemic. Circulation. 2003 Sep 30; 108(13):1552-3. PMID: 14517151.
      Citations: 12     Fields:    Translation:Humans
    214. Willerson JT, Kereiakes DJ. Clinical research and future improvement in clinical care: the Health Insurance Portability and Accountability Act (HIPAA) and future difficulties but optimism for the way forward. Circulation. 2003 Aug 26; 108(8):919-20. PMID: 12939242.
      Citations: 3     Fields:    Translation:Humans
    215. Kereiakes DJ, Willerson JT. Vascular brachytherapy boon or bust? Circulation. 2003 Jul 29; 108(4):389-90. PMID: 12885732.
      Citations:    Fields:    Translation:Humans
    216. Topol EJ, Easton D, Harrington RA, Amarenco P, Califf RM, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Granett J, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Sigmon K, Pieper K, Vallee M, Willerson JT. Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation. 2003 Jul 29; 108(4):399-406. PMID: 12874182.
      Citations: 24     Fields:    Translation:HumansCTClinical Trials
    217. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation. 2003 Jul 01; 107(25):3133-40. PMID: 12796126.
      Citations: 288     Fields:    Translation:HumansCTClinical Trials
    218. Willerson JT. Editor's commentary: One size does not fit all. Circulation. 2003 May 27; 107(20):2543-4. PMID: 12777319.
      Citations:    Fields:    Translation:Humans
    219. Naghavi M, Madjid M, Gul K, Siadaty MS, Litovsky S, Willerson JT, Casscells SW. Thermography basket catheter: in vivo measurement of the temperature of atherosclerotic plaques for detection of vulnerable plaques. Catheter Cardiovasc Interv. 2003 May; 59(1):52-9. PMID: 12720241.
      Citations: 6     Fields:    Translation:Animals
    220. Casscells W, Naghavi M, Willerson JT. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation. 2003 Apr 29; 107(16):2072-5. PMID: 12719287.
      Citations: 45     Fields:    Translation:Humans
    221. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belém L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003 May 13; 107(18):2294-302. PMID: 12707230.
      Citations: 226     Fields:    Translation:HumansCTClinical Trials
    222. Litovsky S, Madjid M, Zarrabi A, Casscells SW, Willerson JT, Naghavi M. Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma. Circulation. 2003 Mar 25; 107(11):1545-9. PMID: 12654614.
      Citations: 22     Fields:    Translation:AnimalsCells
    223. Willerson JT. Editor's commentary: centers of excellence. Circulation. 2003 Mar 25; 107(11):1471-2. PMID: 12654601.
      Citations: 1     Fields:    Translation:Humans
    224. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza RL, Berman DS, Gibson CM, Bajamonde A, Rundle AC, Fine J, McCluskey ER. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation. 2003 Mar 18; 107(10):1359-65. PMID: 12642354.
      Citations: 239     Fields:    Translation:HumansCTClinical Trials
    225. Perin EC, Geng YJ, Willerson JT. Adult stem cell therapy in perspective. Circulation. 2003 Feb 25; 107(7):935-8. PMID: 12600902.
      Citations: 18     Fields:    Translation:Humans
    226. Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003 Jan 28; 107(3):370-1. PMID: 12551854.
      Citations: 77     Fields:    Translation:Humans
    227. González AA, Segura AM, Horiba K, Qian S, Yu ZX, Stetler-Stevenson W, Willerson JT, McAllister HA, Ferrans VJ. Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study. Hum Pathol. 2002 Dec; 33(12):1158-64. PMID: 12514782.
      Citations: 3     Fields:    Translation:Humans
    228. Madjid M, Naghavi M, Malik BA, Litovsky S, Willerson JT, Casscells W. Thermal detection of vulnerable plaque. Am J Cardiol. 2002 Nov 21; 90(10C):36L-39L. PMID: 12459426.
      Citations: 10     Fields:    Translation:HumansAnimals
    229. Chen M, Capps C, Willerson JT, Zoldhelyi P. E2F-1 regulates nuclear factor-kappaB activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1. Circulation. 2002 Nov 19; 106(21):2707-13. PMID: 12438297.
      Citations: 11     Fields:    Translation:HumansCells
    230. Bonow R, Clark EB, Curfman GD, Guttmacher A, Hill MN, Miller DC, Morrison AR, Myerburg RJ, Schneider MD, Weisfeldt ML, Willerson JT, Young JB. Task Force on Strategic Research Direction: Clinical Science Subgroup key science topics report. Circulation. 2002 Nov 12; 106(20):e162-6. PMID: 12427671.
      Citations:    Fields:    Translation:HumansCells
    231. Lincoff AM, Califf RM, Van de Werf F, Willerson JT, White HD, Armstrong PW, Guetta V, Gibler WB, Hochman JS, Bode C, Vahanian A, Steg PG, Ardissino D, Savonitto S, Bar F, Sadowski Z, Betriu A, Booth JE, Wolski K, Waller M, Topol EJ. Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial. JAMA. 2002 Nov 06; 288(17):2130-5. PMID: 12413372.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    232. Zarrabi A, Gul K, Willerson JT, Casscells W, Naghavi M. Intravascular thermography: a novel approach for detection of vulnerable plaque. Curr Opin Cardiol. 2002 Nov; 17(6):656-62. PMID: 12466709.
      Citations: 1     Fields:    Translation:HumansAnimals
    233. Holmes DR, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, Fischman D, Goldberg S, Brinker JA, Zeiher AM, Shapiro LM, Willerson J, Davis BR, Ferguson JJ, Popma J, King SB, Lincoff AM, Tcheng JE, Chan R, Granett JR, Poland M. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation. 2002 Sep 03; 106(10):1243-50. PMID: 12208800.
      Citations: 28     Fields:    Translation:HumansCTClinical Trials
    234. Naghavi M, John R, Naguib S, Siadaty MS, Grasu R, Kurian KC, van Winkle WB, Soller B, Litovsky S, Madjid M, Willerson JT, Casscells W. pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque. Atherosclerosis. 2002 Sep; 164(1):27-35. PMID: 12119190.
      Citations: 34     Fields:    Translation:HumansAnimals
    235. Pitt B, Pepine C, Willerson JT. Cyclooxygenase-2 inhibition and cardiovascular events. Circulation. 2002 Jul 09; 106(2):167-9. PMID: 12105151.
      Citations: 12     Fields:    Translation:Humans
    236. Willerson JT. Systemic and local inflammation in patients with unstable atherosclerotic plaques. Prog Cardiovasc Dis. 2002 May-Jun; 44(6):469-78. PMID: 12077720.
      Citations: 14     Fields:    Translation:Humans
    237. Wang J, Geng YJ, Guo B, Klima T, Lal BN, Willerson JT, Casscells W. Near-infrared spectroscopic characterization of human advanced atherosclerotic plaques. J Am Coll Cardiol. 2002 Apr 17; 39(8):1305-13. PMID: 11955848.
      Citations: 21     Fields:    Translation:HumansAnimals
    238. Willerson JT, Crea F. How to search for the precipitating role of vasoconstriction and its prevalence in myocardial infarction. Ital Heart J. 2002 Apr; 3(4):217-9. PMID: 12025368.
      Citations:    Fields:    Translation:Humans
    239. Golino P, Crea F, Willerson JT. How to study the effects of platelet aggregation and thrombosis on coronary vasomotion and their clinical relevance. Ital Heart J. 2002 Apr; 3(4):220-5. PMID: 12025369.
      Citations: 2     Fields:    Translation:HumansAnimals
    240. Willerson JT. March 26, 2002: rapid access publication. Circulation. 2002 Mar 26; 105(12):1395. PMID: 11914241.
      Citations:    Fields:    Translation:HumansCells
    241. Anderson HV, McNatt J, Clubb FJ, Herman M, Maffrand JP, DeClerck F, Ahn C, Buja LM, Willerson JT. Platelet inhibition reduces cyclic flow variations and neointimal proliferation in normal and hypercholesterolemic-atherosclerotic canine coronary arteries. Circulation. 2001 Nov 06; 104(19):2331-7. PMID: 11696474.
      Citations: 8     Fields:    Translation:Animals
    242. Yeh ET, Anderson HV, Pasceri V, Willerson JT. C-reactive protein: linking inflammation to cardiovascular complications. Circulation. 2001 Aug 28; 104(9):974-5. PMID: 11524386.
      Citations: 29     Fields:    Translation:Humans
    243. Anderson KM, Califf RM, Stone GW, Neumann FJ, Montalescot G, Miller DP, Ferguson JJ, Willerson JT, Weisman HF, Topol EJ. Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol. 2001 Jun 15; 37(8):2059-65. PMID: 11419888.
      Citations: 18     Fields:    Translation:Humans
    244. Pasceri V, Cheng JS, Willerson JT, Yeh ET, Chang J. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation. 2001 May 29; 103(21):2531-4. PMID: 11382718.
      Citations: 126     Fields:    Translation:HumansCells
    245. Wu KK, Willerson JT. Monitoring platelet function in glycoprotein IIB/IIIA inhibitor therapy. Circulation. 2001 May 29; 103(21):2528-30. PMID: 11382717.
      Citations: 5     Fields:    Translation:Humans
    246. Shyue SK, Tsai MJ, Liou JY, Willerson JT, Wu KK. Selective augmentation of prostacyclin production by combined prostacyclin synthase and cyclooxygenase-1 gene transfer. Circulation. 2001 Apr 24; 103(16):2090-5. PMID: 11319200.
      Citations: 7     Fields:    Translation:HumansCells
    247. Zoldhelyi P, Chen ZQ, Shelat HS, McNatt JM, Willerson JT. Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Proc Natl Acad Sci U S A. 2001 Mar 27; 98(7):4078-83. PMID: 11274432.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    248. Naghavi M, Madjid M, Khan MR, Mohammadi RM, Willerson JT, Casscells SW. New developments in the detection of vulnerable plaque. Curr Atheroscler Rep. 2001 Mar; 3(2):125-35. PMID: 11177656.
      Citations: 14     Fields:    Translation:Humans
    249. Lefkowitz RJ, Willerson JT. Prospects for cardiovascular research. JAMA. 2001 Feb 07; 285(5):581-7. PMID: 11176863.
      Citations: 19     Fields:    Translation:HumansAnimals
    250. Shelat HS, Liu TJ, Hickman-Bick DL, Barnhart MK, Vida T, Dillard PM, Willerson JT, Zoldhelyi P. Growth suppression of human coronary vascular smooth muscle cells by gene transfer of the transcription factor E2F-1. Circulation. 2001 Jan 23; 103(3):407-14. PMID: 11157693.
      Citations: 2     Fields:    Translation:HumansCells
    251. Clubb FJ, Cerny JL, Deferrari DA, Butler-Aucoin MM, Willerson JT, Buja LM. Development of atherosclerotic plaque with endothelial disruption in Watanabe heritable hyperlipidemic rabbit aortas. Cardiovasc Pathol. 2001 Jan-Feb; 10(1):1-11. PMID: 11343989.
      Citations: 4     Fields:    Translation:Animals
    252. Stevenson LW, Kormos RL, Bourge RC, Gelijns A, Griffith BP, Hershberger RE, Hunt S, Kirklin J, Miller LW, Pae WE, Pantalos G, Pennington DG, Rose EA, Watson JT, Willerson JT, Young JB, Barr ML, Costanzo MR, Desvigne-Nickens P, Feldman AM, Frazier OH, Friedman L, Hill JD, Konstam MA, McCarthy PM, Michler RE, Oz MC, Rosengard BR, Sapirstein W, Shanker R, Smith CR, Starling RC, Taylor DO, Wichman A. Mechanical cardiac support 2000: current applications and future trial design. June 15-16, 2000 Bethesda, Maryland. J Am Coll Cardiol. 2001 Jan; 37(1):340-70. PMID: 11153769.
      Citations: 7     Fields:    Translation:Humans
    253. Théroux P, Chaitman BR, Danchin N, Erhardt L, Meinertz T, Schroeder JS, Tognoni G, White HD, Willerson JT, Jessel A. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation. 2000 Dec 19; 102(25):3032-8. PMID: 11120691.
      Citations: 64     Fields:    Translation:HumansCTClinical Trials
    254. Jax TW, Eichstaedt HC, Shelat HS, Barnhart MK, Lichtenberg MW, Willerson JT, Zoldhelyi P. [New antithrombotic therapy approaches in coronary heart disease--prospects for gene therapy]. Z Kardiol. 2000 Dec; 89(12):1072-83. PMID: 11201022.
      Citations:    Fields:    Translation:HumansAnimals
    255. Zoldhelyi P, Beck PJ, Bjercke RJ, Ober JC, Hu X, McNatt JM, Akhtar S, Ahmed M, Clubb FJ, Chen ZQ, Dixon RA, Yeh ET, Willerson JT. Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor. . 2000 Dec; 279(6):H3065-75. PMID: 11087265.
      Citations:    
    256. Théroux P, Willerson JT, Armstrong PW. Progress in the treatment of acute coronary syndromes: a 50-year perspective (1950-2000). Circulation. 2000 Nov 14; 102(20 Suppl 4):IV2-IV13. PMID: 11080126.
      Citations: 5     Fields:    Translation:Humans
    257. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000 Oct 31; 102(18):2165-8. PMID: 11056086.
      Citations: 296     Fields:    Translation:HumansCells
    258. Topol EJ, Easton JD, Amarenco P, Califf R, Harrington R, Graffagnino C, Davis S, Diener HC, Ferguson J, Fitzgerald D, Shuaib A, Koudstaal PJ, Theroux P, Van de Werf F, Willerson JT, Chan R, Samuels R, Ilson B, Granett J. Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial. Am Heart J. 2000 Jun; 139(6):927-33. PMID: 10827369.
      Citations: 10     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    259. Pasceri V, Wu HD, Willerson JT, Yeh ET. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation. 2000 Jan 25; 101(3):235-8. PMID: 10645917.
      Citations: 93     Fields:    Translation:HumansAnimalsCells
    260. Zoldhelyi P, McNatt J, Shelat HS, Yamamoto Y, Chen ZQ, Willerson JT. Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor. Circulation. 2000 Jan 25; 101(3):289-95. PMID: 10645925.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    261. Braunwald E, Califf RM, Cannon CP, Fox KA, Fuster V, Gibler WB, Harrington RA, King SB, Kleiman NS, Theroux P, Topol EJ, Van de Werf F, White HD, Willerson JT. Redefining medical treatment in the management of unstable angina. Am J Med. 2000 Jan; 108(1):41-53. PMID: 11059440.
      Citations: 4     Fields:    Translation:Humans
    262. Holmes D, Fitzgerald P, Goldberg S, LaBlanche Jm, Lincoff AM, Savage M, Serruys PW, Willerson J, Granett JR, Chan R, Shusterman NH, Poland M. The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial. Am Heart J. 2000 Jan; 139(1 Pt 1):23-31. PMID: 10618558.
      Citations: 6     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    263. Theroux P, Chaitman BR, Erhardt L, Jessel A, Meinertz T, Nickel WU, Schroeder JS, Tognoni G, White H, Willerson JT. Design of a trial evaluating myocardial cell protection with cariporide, an inhibitor of the transmembrane sodium-hydrogen exchanger: the Guard During Ischemia Against Necrosis (GUARDIAN) trial. Curr Control Trials Cardiovasc Med. 2000; 1(1):59-67. PMID: 11714411.
      Citations:    
    264. Zoldhelyi P, Eichstaedt H, Jax T, McNatt JM, Chen ZQ, Shelat HS, Rose H, Willerson JT. The emerging clinical potential of cardiovascular gene therapy. Semin Interv Cardiol. 1999 Sep; 4(3):151-65. PMID: 10545621.
      Citations:    Fields:    Translation:HumansAnimals
    265. Pasceri V, Willerson JT. Homocysteine and coronary heart disease: a review of the current evidence. Semin Interv Cardiol. 1999 Sep; 4(3):121-8. PMID: 10545618.
      Citations: 3     Fields:    Translation:HumansAnimals
    266. Willerson JT, Zoldhelyi P. Future directions in thrombolysis. Clin Cardiol. 1999 Aug; 22(8 Suppl):IV44-53. PMID: 10492853.
      Citations:    Fields:    Translation:Humans
    267. Folts JD, Schafer AI, Loscalzo J, Willerson JT, Muller JE. A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials. J Am Coll Cardiol. 1999 Feb; 33(2):295-303. PMID: 9973006.
      Citations: 12     Fields:    Translation:HumansAnimals
    268. Delgado RM, Willerson JT. Pathophysiology of heart failure: a look at the future. Tex Heart Inst J. 1999; 26(1):28-33. PMID: 10217468.
      Citations: 1     Fields:    Translation:HumansAnimals
    269. Mann DL, Willerson JT. Left ventricular assist devices and the failing heart: a bridge to recovery, a permanent assist device, or a bridge too far? Circulation. 1998 Dec 01; 98(22):2367-9. PMID: 9832479.
      Citations: 6     Fields:    Translation:Humans
    270. Segura AM, Luna RE, Horiba K, Stetler-Stevenson WG, McAllister HA, Willerson JT, Ferrans VJ. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation. 1998 Nov 10; 98(19 Suppl):II331-7; discussion II337-8. PMID: 9852923.
      Citations: 40     Fields:    Translation:HumansCells
    271. Willerson JT, Delgado R, Mann D. Treating relentlessly progressive congestive heart failure: what next? Tex Heart Inst J. 1998; 25(4):235-7. PMID: 9885098.
      Citations: 1     Fields:    Translation:Humans
    272. Willerson JT. Stable angina pectoris: recent advances in predicting prognosis and treatment. Adv Intern Med. 1998; 43:175-202. PMID: 9506182.
      Citations:    Fields:    Translation:Humans
    273. Patel SS, Thiagarajan R, Willerson JT, Yeh ET. Inhibition of alpha4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation. 1998 Jan 6-13; 97(1):75-81. PMID: 9443434.
      Citations: 34     Fields:    Translation:AnimalsCells
    274. Fuster V, Poon M, Willerson JT. Learning from the transgenic mouse: endothelium, adhesive molecules, and neointimal formation. Circulation. 1998 Jan 6-13; 97(1):16-8. PMID: 9443425.
      Citations: 6     Fields:    Translation:HumansAnimals
    275. Fujise K, Stacy L, Beck P, Yeh ET, Chuang A, Brock TA, Willerson JT. Differential effects of endothelin receptor activation on cyclic flow variations in rat mesenteric arteries. Circulation. 1997 Nov 18; 96(10):3641-6. PMID: 9396466.
      Citations:    Fields:    Translation:Animals
    276. Muller JE, Kaufmann PG, Luepker RV, Weisfeldt ML, Deedwania PC, Willerson JT. Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events Participants. Circulation. 1997 Nov 04; 96(9):3233-9. PMID: 9386197.
      Citations: 16     Fields:    Translation:Humans
    277. Pakala R, Willerson JT, Benedict CR. Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation. Circulation. 1997 Oct 07; 96(7):2280-6. PMID: 9337201.
      Citations: 13     Fields:    Translation:AnimalsCells
    278. McGhie AI, Radovancevic B, Capek P, Moore WH, Kasi L, Lamki L, Clubb FJ, Frazier OH, Willerson JT. Major histocompatibility complex class II antigen expression in rejecting cardiac allografts: detection using in vivo imaging with radiolabeled monoclonal antibody. Circulation. 1997 Sep 02; 96(5):1605-11. PMID: 9315554.
      Citations: 1     Fields:    Translation:Animals
    279. Golino P, Ambrosio G, Ragni M, Cirillo P, Esposito N, Willerson JT, Rothlein R, Petrucci L, Condorelli M, Chiariello M, Buja LM. Inhibition of leucocyte and platelet adhesion reduces neointimal hyperplasia after arterial injury. Thromb Haemost. 1997 Apr; 77(4):783-8. PMID: 9134659.
      Citations: 2     Fields:    Translation:AnimalsCells
    280. Willerson JT. James Thornton Willerson, MD: a conversation with the editor. Interview by William Clifford Roberts. Am J Cardiol. 1997 Feb 15; 79(4):457-67. PMID: 9052350.
      Citations:    Fields:    Translation:Humans
    281. Fujise K, Revelle BM, Stacy L, Madison EL, Yeh ET, Willerson JT, Beck PJ. A tissue plasminogen activator/P-selectin fusion protein is an effective thrombolytic agent. Circulation. 1997 Feb 04; 95(3):715-22. PMID: 9024162.
      Citations: 3     Fields:    Translation:AnimalsCells
    282. Willerson JT. Pharmacologic approaches to reperfusion injury. Adv Pharmacol. 1997; 39:291-312. PMID: 9160118.
      Citations: 11     Fields:    Translation:HumansAnimals
    283. Willerson JT. Effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 1996 Dec 15; 94(12):3054. PMID: 8989104.
      Citations: 1     Fields:    Translation:Humans
    284. Schulman SP, Goldschmidt-Clermont PJ, Topol EJ, Califf RM, Navetta FI, Willerson JT, Chandra NC, Guerci AD, Ferguson JJ, Harrington RA, Lincoff AM, Yakubov SJ, Bray PF, Bahr RD, Wolfe CL, Yock PG, Anderson HV, Nygaard TW, Mason SJ, Effron MB, Fatterpacker A, Raskin S, Smith J, Brashears L, Gottdiener P, du Mee C, Kitt MM, Gerstenblith G. Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial. Circulation. 1996 Nov 01; 94(9):2083-9. PMID: 8901655.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    285. Willerson JT. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. Circulation. 1996 Sep 15; 94(6):1194. PMID: 8822965.
      Citations: 1     Fields:    Translation:Humans
    286. Willerson JT. Inhibitors of platelet glycoprotein IIb/IIIa receptors. Will they be useful when given chronically? Circulation. 1996 Sep 01; 94(5):866-8. PMID: 8790016.
      Citations: 2     Fields:    Translation:Humans
    287. Casscells W, Hathorn B, David M, Krabach T, Vaughn WK, McAllister HA, Bearman G, Willerson JT. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet. 1996 May 25; 347(9013):1447-51. PMID: 8676628.
      Citations: 36     Fields:    Translation:HumansCells
    288. Willerson JT, Teaff R. Egyptian contributions to cardiovascular medicine. Tex Heart Inst J. 1996; 23(3):191-200. PMID: 8885101.
      Citations: 6     Fields:    
    289. Willerson JT, Igo SR, Yao SK, Ober JC, Macris MP, Ferguson JJ. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries. Tex Heart Inst J. 1996; 23(1):1-8. PMID: 8680268.
      Citations: 5     Fields:    Translation:Animals
    290. Ballantyne CM, Masri BM, Clubb FJ, Radovancevic B, Smith CW, Hawkins HK, Frazier OH, Willerson JT. Increased expression of ICAM-1 in a case of accelerated coronary artery disease after heart transplantation. Tex Heart Inst J. 1996; 23(4):293-5. PMID: 8969030.
      Citations:    Fields:    Translation:Humans
    291. Zoldhelyi P, McNatt J, Xu XM, Loose-Mitchell D, Meidell RS, Clubb FJ, Buja LM, Willerson JT, Wu KK. Prevention of arterial thrombosis by adenovirus-mediated transfer of cyclooxygenase gene. Circulation. 1996 Jan 01; 93(1):10-7. PMID: 8616915.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    292. Anderson HV, Cannon CP, Stone PH, Williams DO, McCabe CH, Knatterud GL, Thompson B, Willerson JT, Braunwald E. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 1995 Dec; 26(7):1643-50. PMID: 7594098.
      Citations: 29     Fields:    Translation:HumansCTClinical Trials
    293. Anderson HV, Kirkeeide RL, Willerson JT, Smalling RW, Schroth G. Coronary artery flow monitoring: the value of intravascular Doppler for detection of complications after interventions. Eur Heart J. 1995 Nov; 16 Suppl L:93-6. PMID: 8869026.
      Citations:    Fields:    Translation:Humans
    294. Anderson HV, Kirkeeide RL, Willerson JT, Mishkel DC, Kjellgren O, Smalling RW, Schroth G. Coronary artery flow monitoring following coronary interventions. Eur Heart J. 1995 Oct; 16 Suppl J:71-3. PMID: 8746941.
      Citations:    Fields:    Translation:Humans
    295. Willerson JT. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Circulation. 1995 Sep 15; 92(6):1375. PMID: 7664412.
      Citations:    Fields:    Translation:Humans
    296. Yao SK, Akhtar S, Scott-Burden T, Ober JC, Golino P, Buja LM, Casscells W, Willerson JT. Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis. Circulation. 1995 Aug 15; 92(4):1005-10. PMID: 7641335.
      Citations: 7     Fields:    Translation:Animals
    297. Willerson JT. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Circulation. 1995 Aug 01; 92(3):277. PMID: 7634434.
      Citations:    Fields:    Translation:Animals
    298. Mueller HW, Haught CA, McNatt JM, Cui K, Gaskell SJ, Johnston DA, Willerson JT. Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease. Circ Res. 1995 Jul; 77(1):54-63. PMID: 7788882.
      Citations: 6     Fields:    Translation:HumansAnimals
    299. Casscells W, Willerson JT. Amphotropic but not atherotropic: another caveat for adenoviral gene therapy. J Clin Invest. 1995 Jun; 95(6):2425-6. PMID: 7769084.
      Citations: 2     Fields:    Translation:AnimalsCells
    300. McGhie AL, Faber TL, Willerson JT, Corbett JR. Evaluation of left ventricular aneurysm after acute myocardial infarction using tomographic radionuclide ventriculography. Am J Cardiol. 1995 Apr 01; 75(10):720-4. PMID: 7900669.
      Citations: 2     Fields:    Translation:Humans
    301. Willerson JT, Zoldhelyi P, Meidell R, McNatt J, Xu XM, Wu KK. Gene therapy to restore prostacyclin presence to injured endothelium. Trans Am Clin Climatol Assoc. 1995; 106:100-7; discussion 107-8. PMID: 7483165.
      Citations:    Fields:    Translation:HumansAnimalsCells
    302. Willerson JT. Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products. Tex Heart Inst J. 1995; 22(1):13-9. PMID: 7787465.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    303. Wu KK, Zoldhelyi P, Willerson JT, Meidell R, McNatt J, Xu XM. Restoration of prostacyclin synthesis by transfer of prostaglandin H synthase cDNA. Adv Prostaglandin Thromboxane Leukot Res. 1995; 23:377-9. PMID: 7732876.
      Citations:    Fields:    Translation:HumansAnimalsCells
    304. McGhie AI, McNatt J, Ezov N, Cui K, Mower LK, Hagay Y, Buja LM, Garfinkel LI, Gorecki M, Willerson JT. Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain. Circulation. 1994 Dec; 90(6):2976-81. PMID: 7994845.
      Citations: 6     Fields:    Translation:AnimalsCells
    305. Casscells W, Willerson JT. Medicare's support of academic medical centers. Circulation. 1994 Nov; 90(5):2554-5. PMID: 7955217.
      Citations:    Fields:    Translation:Humans
    306. Pakala R, Willerson JT, Benedict CR. Mitogenic effect of serotonin on vascular endothelial cells. Circulation. 1994 Oct; 90(4):1919-26. PMID: 7923680.
      Citations: 22     Fields:    Translation:AnimalsCells
    307. Yao SK, Ober JC, Ferguson JJ, Maffrand JP, Anderson HV, Buja LM, Willerson JT. Clopidogrel is more effective than aspirin as adjuvant treatment to prevent reocclusion after thrombolysis. Am J Physiol. 1994 Aug; 267(2 Pt 2):H488-93. PMID: 8067400.
      Citations: 5     Fields:    Translation:Animals
    308. Willerson JT. James B. Herrick Memorial Lecture. Circulation. 1994 Apr; 89(4):1875-81. PMID: 8149552.
      Citations:    Fields:    Translation:Humans
    309. Anderson HV, Kirkeeide RL, Krishnaswami A, Weigelt LA, Revana M, Weisman HF, Willerson JT. Cyclic flow variations after coronary angioplasty in humans: clinical and angiographic characteristics and elimination with 7E3 monoclonal antiplatelet antibody. J Am Coll Cardiol. 1994 Apr; 23(5):1031-7. PMID: 8144764.
      Citations: 8     Fields:    Translation:Humans
    310. Willerson JT, Yao SK, McNatt J, Cui K, Anderson HV, Swensen C, Ostro M, Buja LM. Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. Circulation. 1994 Apr; 89(4):1786-91. PMID: 8149544.
      Citations: 1     Fields:    Translation:Animals
    311. Smalling RW, Sweeney M, Lachterman B, Hess MJ, Morris R, Anderson HV, Heibig J, Li G, Willerson JT, Frazier H, et al. Transvalvular left ventricular assistance in cardiogenic shock secondary to acute myocardial infarction. Evidence for recovery from near fatal myocardial stunning. J Am Coll Cardiol. 1994 Mar 01; 23(3):637-44. PMID: 8113546.
      Citations: 4     Fields:    Translation:Humans
    312. Golino P, Piscione F, Benedict CR, Anderson HV, Cappelli-Bigazzi M, Indolfi C, Condorelli M, Chiariello M, Willerson JT. Local effect of serotonin released during coronary angioplasty. N Engl J Med. 1994 Feb 24; 330(8):523-8. PMID: 8043066.
      Citations: 20     Fields:    Translation:Humans
    313. Casscells W, Engler D, Willerson JT. Mechanisms of restenosis. Tex Heart Inst J. 1994; 21(1):68-77. PMID: 8180514.
      Citations: 4     Fields:    Translation:HumansAnimals
    314. Buja LM, Willerson JT. Role of inflammation in coronary plaque disruption. Circulation. 1994 Jan; 89(1):503-5. PMID: 8281687.
      Citations: 25     Fields:    Translation:HumansCells
    315. Wu KK, Zoldhelyi P, Willerson JT, Xu XM, Loose-Mitchell DS, Wang LH. Gene therapy for vascular diseases. Tex Heart Inst J. 1994; 21(1):98-103. PMID: 8180517.
      Citations: 1     Fields:    Translation:Humans
    316. Benedict CR, Pakala R, Willerson JT. Endothelial-dependent procoagulant and anticoagulant mechanisms. Recent advances in understanding. Tex Heart Inst J. 1994; 21(1):86-90. PMID: 8180515.
      Citations: 1     Fields:    Translation:Animals
    317. Terrin ML, Williams DO, Kleiman NS, Willerson J, Mueller HS, Desvigne-Nickens P, Forman SA, Knatterud GL, Braunwald E. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial. J Am Coll Cardiol. 1993 Dec; 22(7):1763-72. PMID: 8245326.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    318. Yao SK, McNatt J, Cui K, Anderson HV, Maffrand JP, Buja LM, Willerson JT. Combined ADP and thromboxane A2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in nonhuman primates. Circulation. 1993 Dec; 88(6):2888-93. PMID: 8252702.
      Citations: 7     Fields:    Translation:HumansAnimals
    319. Yao SK, Ober JC, Gonenne A, Clubb FJ, Krishnaswami A, Ferguson JJ, Anderson HV, Gorecki M, Buja LM, Willerson JT. Active oxygen species play a role in mediating platelet aggregation and cyclic flow variations in severely stenosed and endothelium-injured coronary arteries. Circ Res. 1993 Nov; 73(5):952-67. PMID: 8403265.
      Citations: 13     Fields:    Translation:Animals
    320. Willerson JT, Buja LM. A 17-year-old woman with a history of sexually transmitted disease and productive cough who developed cardiogenic shock. Circulation. 1993 Oct; 88(4 Pt 1):1945-51. PMID: 8403341.
      Citations:    Fields:    Translation:Humans
    321. Anderson HV, Willerson JT. Thrombolysis in acute myocardial infarction. N Engl J Med. 1993 Sep 02; 329(10):703-9. PMID: 8345856.
      Citations: 20     Fields:    Translation:Humans
    322. Willerson JT, Chen PC, Hartwell EA, Buja LM. Congestive heart failure in a 70-year-old man. Circulation. 1993 Sep; 88(3):1336-47. PMID: 8353894.
      Citations:    Fields:    Translation:Humans
    323. Anderson HV, Vignale SJ, Benedict CR, Willerson JT. Restenosis after coronary angioplasty. J Interv Cardiol. 1993 Sep; 6(3):187-202. PMID: 10151016.
      Citations: 1     Fields:    Translation:Humans
    324. Willerson JT, Guthrie AM, Buja LM. Chest pain in a 26-year-old woman with a history of systemic lupus erythematosus and hypertension. Circulation. 1993 Aug; 88(2):787-96. PMID: 8339438.
      Citations:    Fields:    Translation:Humans
    325. Anderson HV, Kirkeeide RL, Stuart Y, Smalling RW, Heibig J, Willerson JT. Coronary artery flow monitoring following coronary interventions. Am J Cardiol. 1993 May 20; 71(14):62D-69D. PMID: 8488777.
      Citations:    Fields:    Translation:Humans
    326. Topol EJ, Bonan R, Jewitt D, Sigwart U, Kakkar VV, Rothman M, de Bono D, Ferguson J, Willerson JT, Strony J, et al. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty. Circulation. 1993 May; 87(5):1622-9. PMID: 8491018.
      Citations: 21     Fields:    Translation:HumansCellsCTClinical Trials
    327. Willerson JT, Casscells W. Thrombin inhibitors in unstable angina: rebound or continuation of angina after argatroban withdrawal? J Am Coll Cardiol. 1993 Apr; 21(5):1048-51. PMID: 8459056.
      Citations: 2     Fields:    Translation:Humans
    328. Yao SK, Ober JC, Ferguson JJ, Maffrand JP, Anderson HV, Buja LM, Willerson JT. Clopidogrel is more effective than aspirin in preventing coronary artery reocclusion after thrombolysis. Trans Assoc Am Physicians. 1993; 106:110-9. PMID: 8036734.
      Citations: 2     Fields:    Translation:Animals
    329. Yao SK, Ober JC, Ferguson JJ, Anderson HV, Maraganore J, Buja LM, Willerson JT. Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries. Circulation. 1992 Dec; 86(6):1993-9. PMID: 1451271.
      Citations: 3     Fields:    Translation:Animals
    330. Yao SK, Ober JC, Krishnaswami A, Ferguson JJ, Anderson HV, Golino P, Buja LM, Willerson JT. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation. 1992 Oct; 86(4):1302-9. PMID: 1394936.
      Citations: 27     Fields:    Translation:Animals
    331. McGhie AI, Willerson JT. Noninvasive evaluation of myocardial perfusion with use of technetium-99m teboroxime. J Am Coll Cardiol. 1992 Sep; 20(3):720-1. PMID: 1512354.
      Citations:    Fields:    Translation:Animals
    332. Thandroyen FT, Bellotto D, Katayama A, Hagler HK, Willerson JT, Buja LM. Subcellular electrolyte alterations during progressive hypoxia and following reoxygenation in isolated neonatal rat ventricular myocytes. Circ Res. 1992 Jul; 71(1):106-19. PMID: 1606659.
      Citations: 3     Fields:    Translation:AnimalsCells
    333. Benedict CR, Mueller S, Anderson HV, Willerson JT. Thrombolytic therapy: a state of the art review. Hosp Pract (Off Ed). 1992 Jun 15; 27(6):61-72. PMID: 1534563.
      Citations:    Fields:    Translation:Humans
    334. Anderson HV, Revana M, Rosales O, Brannigan L, Stuart Y, Weisman H, Willerson JT. Intravenous administration of monoclonal antibody to the platelet GP IIb/IIIa receptor to treat abrupt closure during coronary angioplasty. Am J Cardiol. 1992 May 15; 69(16):1373-6. PMID: 1585878.
      Citations: 1     Fields:    Translation:Humans
    335. Buja LM, Willerson JT. Effects of serotonin and thromboxane A2 on the coronary collateral circulation. J Am Coll Cardiol. 1992 Mar 01; 19(3):694-5. PMID: 1538029.
      Citations: 1     Fields:    Translation:Animals
    336. Yao SK, McNatt J, Anderson HV, Eidt J, Cui KX, Golino P, Glas-Greenwalt P, Maraganore J, Buja LM, Willerson JT. Thrombin inhibition enhances tissue-type plasminogen activator-induced thrombolysis and delays reocclusion. Am J Physiol. 1992 Feb; 262(2 Pt 2):H374-9. PMID: 1539695.
      Citations: 1     Fields:    Translation:Animals
    337. Ferguson JJ, Willerson JT. Lipids, atherosclerosis, and restenosis after percutaneous transluminal coronary angioplasty. Tex Heart Inst J. 1992; 19(1):54-61. PMID: 15227471.
      Citations: 2     Fields:    
    338. Willerson JT, Mueller SD, Ferguson JJ. Should all patients with risk factors for ischemic heart disease receive aspirin? Tex Heart Inst J. 1992; 19(2):73-8. PMID: 15227418.
      Citations: 1     Fields:    
    339. Carry M, Korley V, Willerson JT, Weigelt L, Ford-Hutchinson AW, Tagari P. Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation. Circulation. 1992 Jan; 85(1):230-6. PMID: 1309444.
      Citations: 25     Fields:    Translation:HumansCells
    340. Willerson JT, Yao SK, McNatt J, Benedict CR, Anderson HV, Golino P, Murphree SS, Buja LM. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc Natl Acad Sci U S A. 1991 Dec 01; 88(23):10624-8. PMID: 1961728.
      Citations: 10     Fields:    Translation:Animals
    341. Willerson JT, Frazier OH. Reducing mortality in patients with extensive myocardial infarction. N Engl J Med. 1991 Oct 17; 325(16):1166-8. PMID: 1891026.
      Citations: 1     Fields:    Translation:Humans
    342. Thandroyen FT, Morris AC, Hagler HK, Ziman B, Pai L, Willerson JT, Buja LM. Intracellular calcium transients and arrhythmia in isolated heart cells. Circ Res. 1991 Sep; 69(3):810-9. PMID: 1873874.
      Citations: 16     Fields:    Translation:AnimalsCells
    343. McGhie AI, Willerson JT, Corbett JR. Radionuclide assessment of ventricular function and risk stratification after myocardial infarction. Circulation. 1991 Sep; 84(3 Suppl):I167-76. PMID: 1884482.
      Citations: 6     Fields:    Translation:Humans
    344. Schaefer S, Lange RA, Gutekunst DP, Parkey RW, Willerson JT, Peshock RM. Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium. Invest Radiol. 1991 Jun; 26(6):551-6. PMID: 1860761.
      Citations: 2     Fields:    Translation:Animals
    345. Bush HS, Ferguson JJ, Angelini P, Willerson JT. Twelve-lead electrocardiographic evaluation of ischemia during percutaneous transluminal coronary angioplasty and its correlation with acute reocclusion. Am Heart J. 1991 Jun; 121(6 Pt 1):1591-9. PMID: 2035373.
      Citations: 3     Fields:    Translation:Humans
    346. Willerson JT, Eidt JF, McNatt J, Yao SK, Golino P, Anderson HV, Buja LM. Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury. J Am Coll Cardiol. 1991 May; 17(6 Suppl B):101B-110B. PMID: 2016468.
      Citations: 2     Fields:    Translation:Animals
    347. Willerson JT, Golino P, McNatt J, Eidt J, Yao SK, Buja LM. Thrombolytic therapy: enhancement by platelet and platelet-derived mediator antagonists. Mol Biol Med. 1991 Apr; 8(2):235-43. PMID: 1806765.
      Citations:    Fields:    Translation:HumansAnimals
    348. Yao SK, Benedict CR, Rosolowsky M, McNatt J, Falinska B, Campbell WB, Buja LM, Willerson JT. Effect of aspirin on local prostaglandin production and serotonin accumulation in a canine model with coronary cyclic flow variations or thrombosis. J Mol Cell Cardiol. 1991 Apr; 23(4):473-82. PMID: 1942081.
      Citations: 6     Fields:    Translation:Animals
    349. Golino P, Piscione F, Willerson JT, Cappelli-Bigazzi M, Focaccio A, Villari B, Indolfi C, Russolillo E, Condorelli M, Chiariello M. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med. 1991 Mar 07; 324(10):641-8. PMID: 1994246.
      Citations: 42     Fields:    Translation:Humans
    350. Roberts R, Rogers WJ, Mueller HS, Lambrew CT, Diver DJ, Smith HC, Willerson JT, Knatterud GL, Forman S, Passamani E, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation. 1991 Feb; 83(2):422-37. PMID: 1671346.
      Citations: 40     Fields:    Translation:HumansCTClinical Trials
    351. Willerson JT, Buja LM. Technetium-99m pyrophosphate and indium-111 antimyosin antibody scintigraphy appear to be comparable methods for infarct detection. J Am Coll Cardiol. 1991 Feb; 17(2):527-9. PMID: 1846889.
      Citations:    Fields:    Translation:Animals
    352. McGhie AI, Corbett JR, Akers MS, Kulkarni P, Sills MN, Kremers M, Buja LM, Durant-Reville M, Parkey RW, Willerson JT. Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction. Am J Cardiol. 1991 Feb 01; 67(4):236-42. PMID: 1990785.
      Citations: 28     Fields:    Translation:Humans
    353. Willerson JT, Golino P, McNatt J, Eidt J, Yao SK, Buja LM. Role of new antiplatelet agents as adjunctive therapies in thrombolysis. Am J Cardiol. 1991 Jan 25; 67(3):12A-18A. PMID: 1990781.
      Citations:    Fields:    Translation:HumansAnimals
    354. Buja LM, Willerson JT. Relationship of ischemic heart disease to sudden death. J Forensic Sci. 1991 Jan; 36(1):25-33. PMID: 2007875.
      Citations: 2     Fields:    Translation:Humans
    355. Ferguson JJ, Ober JC, Edelman SK, Buja LM, Willerson JT. Documentation of experimentally induced thrombus formation using intravascular ultrasound. Tex Heart Inst J. 1991; 18(3):179-85. PMID: 15227477.
      Citations:    Fields:    
    356. Willerson JT, Yao SK, Ferguson JJ, Anderson HV, Golino P, Buja LM. Unstable angina pectoris and the progression to acute myocardial infarction. Role of platelets and platelet-derived mediators. Tex Heart Inst J. 1991; 18(4):243-7. PMID: 15227406.
      Citations: 2     Fields:    
    357. Golino P, Willerson JT. Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies. Tex Heart Inst J. 1991; 18(1):50-61. PMID: 15227508.
      Citations: 1     Fields:    
    358. Eichhorn EJ, Grayburn PA, Willard JE, Anderson HV, Bedotto JB, Carry M, Kahn JK, Willerson JT. Spontaneous alterations in coronary blood flow velocity before and after coronary angioplasty in patients with severe angina. J Am Coll Cardiol. 1991 Jan; 17(1):43-52. PMID: 1987239.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    359. Willerson JT, Golino P, Eidt J, Yao SK, Buja LM. Potential usefulness of combined thromboxane A2 and serotonin receptor blockade for preventing the conversion from chronic to acute coronary artery disease syndromes. Am J Cardiol. 1990 Nov 06; 66(16):48G-53G. PMID: 2146868.
      Citations: 1     Fields:    Translation:Animals
    360. Golino P, Rosolowsky M, Yao SK, McNatt J, De Clerck F, Buja LM, Willerson JT. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis. J Clin Invest. 1990 Oct; 86(4):1095-102. PMID: 2145320.
      Citations: 4     Fields:    Translation:Animals
    361. Willerson JT. Technetium-99m MIBI as a myocardial perfusion agent. Circulation. 1990 Sep; 82(3):1067-9. PMID: 2393995.
      Citations:    Fields:    Translation:HumansAnimals
    362. Yao SK, Rosolowsky M, Anderson HV, Golino P, NcNatt JM, De Clerck F, Buja LM, Willerson JT. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations. J Am Coll Cardiol. 1990 Sep; 16(3):705-13. PMID: 2143767.
      Citations: 5     Fields:    Translation:Animals
    363. Thandroyen FT, Muntz KH, Buja LM, Willerson JT. Alterations in beta-adrenergic receptors, adenylate cyclase, and cyclic AMP concentrations during acute myocardial ischemia and reperfusion. Circulation. 1990 Sep; 82(3 Suppl):II30-7. PMID: 1975523.
      Citations: 2     Fields:    Translation:Animals
    364. Buja LM, Fattor RA, Miller JC, Chien KR, Willerson JT. Effects of calcium loading and impaired energy production on metabolic and ultrastructural features of cell injury in cultured neonatal rat cardiac myocytes. Lab Invest. 1990 Sep; 63(3):320-31. PMID: 2168502.
      Citations:    Fields:    Translation:AnimalsCells
    365. Buja LM, Clubb FJ, Bilheimer DW, Willerson JT. Pathobiology of human familial hypercholesterolaemia and a related animal model, the Watanabe heritable hyperlipidaemic rabbit. Eur Heart J. 1990 Aug; 11 Suppl E:41-52. PMID: 2226533.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    366. Willerson JT, Golino P, Eidt J, Yao S, Buja LM. Evidence that combined thromboxane A2 and serotonin receptor blockade might prevent coronary artery thrombosis and the conversion from chronic to acute coronary heart disease syndromes. Blood Coagul Fibrinolysis. 1990 Jun; 1(2):211-8. PMID: 2130933.
      Citations:    Fields:    Translation:HumansAnimals
    367. Willerson JT, Buja LM. Protection of the myocardium during myocardial infarction: pharmacologic protection during thrombolytic therapy. Am J Cardiol. 1990 May 22; 65(19):35I-41I. PMID: 2186610.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    368. Taylor AL, Golino P, Eckels R, Pastor P, Buja LM, Willerson JT. Differential enhancement of postischemic segmental systolic thickening by diltiazem. J Am Coll Cardiol. 1990 Mar 01; 15(3):737-47. PMID: 2303644.
      Citations: 6     Fields:    Translation:Animals
    369. Golino P, Buja LM, Yao SK, McNatt J, Willerson JT. Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo. J Am Coll Cardiol. 1990 Mar 01; 15(3):718-26. PMID: 2105989.
      Citations: 4     Fields:    Translation:AnimalsCells
    370. Willerson JT, Buja LM. Potential of combined thromboxane A2 and serotonin antagonists to prevent the development of unstable angina and acute myocardial infarction. Tex Heart Inst J. 1990; 17(3):157-64. PMID: 15227166.
      Citations: 1     Fields:    
    371. Yao SK, McNatt JM, Anderson HV, Eidt JF, Cui KX, Golino P, Glas-Greenwalt P, Maraganore JM, Buja LM, Willerson JT. Thrombin inhibition and coronary artery thrombolysis. Trans Assoc Am Physicians. 1990; 103:1-9. PMID: 2132522.
      Citations:    Fields:    Translation:Animals
    372. Peshock RM, Rokey R, Malloy GM, McNamee P, Buja LM, Parkey RW, Willerson JT. Assessment of myocardial systolic wall thickening using nuclear magnetic resonance imaging. J Am Coll Cardiol. 1989 Sep; 14(3):653-9. PMID: 2768713.
      Citations: 4     Fields:    Translation:HumansAnimals
    373. Eidt JF, Ashton J, Golino P, McNatt J, Buja LM, Willerson JT. Thromboxane A2 and serotonin mediate coronary blood flow reductions in unsedated dogs. Am J Physiol. 1989 Sep; 257(3 Pt 2):H873-82. PMID: 2782444.
      Citations: 9     Fields:    Translation:Animals
    374. Jones RL, Miller JC, Hagler HK, Chien KR, Willerson JT, Buja LM. Association between inhibition of arachidonic acid release and prevention of calcium loading during ATP depletion in cultured rat cardiac myocytes. Am J Pathol. 1989 Sep; 135(3):541-56. PMID: 2506756.
      Citations: 8     Fields:    Translation:AnimalsCells
    375. Parsons D, Burton KP, Hagler HK, Willerson JT, Buja LM. Tension and electrolyte changes with Na+-K+ pump inhibition in rat papillary muscle. Am J Physiol. 1989 Sep; 257(3 Pt 2):H942-53. PMID: 2551192.
      Citations: 1     Fields:    Translation:Animals
    376. Schaefer S, Lange RA, Kulkarni PV, Katz J, Parkey RW, Willerson JT, Peshock RM. In vivo nuclear magnetic resonance imaging of myocardial perfusion using the paramagnetic contrast agent manganese gluconate. J Am Coll Cardiol. 1989 Aug; 14(2):472-80. PMID: 2754132.
      Citations: 1     Fields:    Translation:Animals
    377. Eidt JF, Ashton J, Golino P, McNatt J, Buja LM, Willerson JT. Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury. J Clin Invest. 1989 Aug; 84(2):517-27. PMID: 2760199.
      Citations: 2     Fields:    Translation:Animals
    378. Eidt JF, Allison P, Noble S, Ashton J, Golino P, McNatt J, Buja LM, Willerson JT. Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest. 1989 Jul; 84(1):18-27. PMID: 2661588.
      Citations: 27     Fields:    Translation:Animals
    379. Stone PH, Muller JE, Hartwell T, York BJ, Rutherford JD, Parker CB, Turi ZG, Strauss HW, Willerson JT, Robertson T, et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. J Am Coll Cardiol. 1989 Jul; 14(1):49-57. PMID: 2661630.
      Citations: 71     Fields:    Translation:Humans
    380. Clubb FJ, Schmitz JM, Butler MM, Buja LM, Willerson JT, Campbell WB. Effect of dietary omega-3 fatty acid on serum lipids, platelet function, and atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis. 1989 Jul-Aug; 9(4):529-37. PMID: 2751481.
      Citations: 5     Fields:    Translation:AnimalsCells
    381. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications. Circulation. 1989 Jul; 80(1):198-205. PMID: 2661053.
      Citations: 43     Fields:    Translation:HumansAnimalsCells
    382. Kahn JK, McGhie I, Akers MS, Sills MN, Faber TL, Kulkarni PV, Willerson JT, Corbett JR. Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease. Circulation. 1989 Jun; 79(6):1282-93. PMID: 2785873.
      Citations: 58     Fields:    Translation:Humans
    383. Morris AC, Hagler HK, Willerson JT, Buja LM. Relationship between calcium loading and impaired energy metabolism during Na+, K+ pump inhibition and metabolic inhibition in cultured neonatal rat cardiac myocytes. J Clin Invest. 1989 Jun; 83(6):1876-87. PMID: 2542375.
      Citations: 3     Fields:    Translation:AnimalsCells
    384. Thandroyen FT, Muntz K, Rosenbaum T, Ziman B, Willerson JT, Buja LM. Beta-receptor-adenylate cyclase coupling in hypoxic neonatal rat ventricular myocytes. Am J Physiol. 1989 Apr; 256(4 Pt 2):H1209-17. PMID: 2539754.
      Citations: 3     Fields:    Translation:AnimalsCells
    385. Golino P, Ashton JH, McNatt J, Glas-Greenwalt P, Yao SK, O'Brien RA, Buja LM, Willerson JT. Simultaneous administration of thromboxane A2- and serotonin S2-receptor antagonists markedly enhances thrombolysis and prevents or delays reocclusion after tissue-type plasminogen activator in a canine model of coronary thrombosis. Circulation. 1989 Apr; 79(4):911-9. PMID: 2494005.
      Citations: 6     Fields:    Translation:Animals
    386. Wines PA, Schmitz JM, Pfister SL, Clubb FJ, Buja LM, Willerson JT, Campbell WB. Augmented vasoconstrictor responses to serotonin precede development of atherosclerosis in aorta of WHHL rabbit. Arteriosclerosis. 1989 Mar-Apr; 9(2):195-202. PMID: 2647071.
      Citations: 2     Fields:    Translation:Animals
    387. Ashton JH, Golino P, McNatt JM, Buja LM, Willerson JT. Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries. J Am Coll Cardiol. 1989 Mar 01; 13(3):755-63. PMID: 2521875.
      Citations: 7     Fields:    Translation:Animals
    388. van den Berg EK, Schmitz JM, Benedict CR, Malloy CR, Willerson JT, Dehmer GJ. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation. 1989 Jan; 79(1):116-24. PMID: 2910538.
      Citations: 26     Fields:    Translation:Humans
    389. Willerson JT, Buja LM. Q-wave versus non-Q-wave myocardial infarction. Cardiovasc Clin. 1989; 20(1):183-95. PMID: 2653631.
      Citations:    Fields:    Translation:Humans
    390. Golino P, Ashton JH, Buja LM, Rosolowsky M, Taylor AL, McNatt J, Campbell WB, Willerson JT. Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators. Circulation. 1989 Jan; 79(1):154-66. PMID: 2910540.
      Citations: 20     Fields:    Translation:AnimalsCells
    391. McBride W, Jackman JD, Gammon RS, Willerson JT. High-output cardiac failure in patients with multiple myeloma. N Engl J Med. 1988 Dec 22; 319(25):1651-3. PMID: 3200279.
      Citations: 5     Fields:    Translation:Humans
    392. Buja LM, Hagler HK, Willerson JT. Altered calcium homeostasis in the pathogenesis of myocardial ischemic and hypoxic injury. Cell Calcium. 1988 Dec; 9(5-6):205-17. PMID: 3066489.
      Citations: 9     Fields:    Translation:HumansCells
    393. Muntz KH, Calianos TA, Buja LM, Willerson JT, Bernatowicz M, Homcy CJ, Graham RM. Electron microscopic localization of the beta-adrenergic receptor using a ferritin-alprenolol probe. Mol Pharmacol. 1988 Oct; 34(4):444-51. PMID: 2845247.
      Citations: 1     Fields:    Translation:AnimalsCells
    394. Schaefer S, Malloy CR, Katz J, Parkey RW, Buja LM, Willerson JT, Peshock RM. Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. J Am Coll Cardiol. 1988 Oct; 12(4):1064-72. PMID: 3417979.
      Citations: 13     Fields:    Translation:Animals
    395. Sen A, Miller JC, Reynolds R, Willerson JT, Buja LM, Chien KR. Inhibition of the release of arachidonic acid prevents the development of sarcolemmal membrane defects in cultured rat myocardial cells during adenosine triphosphate depletion. J Clin Invest. 1988 Oct; 82(4):1333-8. PMID: 3139713.
      Citations: 11     Fields:    Translation:AnimalsCells
    396. Dehmer GJ, Popma JJ, van den Berg EK, Eichhorn EJ, Prewitt JB, Campbell WB, Jennings L, Willerson JT, Schmitz JM. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N Engl J Med. 1988 Sep 22; 319(12):733-40. PMID: 2842680.
      Citations: 36     Fields:    Translation:HumansCellsCTClinical Trials
    397. Golino P, Buja LM, Ashton JH, Kulkarni P, Taylor A, Willerson JT. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries. Circulation. 1988 Sep; 78(3):701-11. PMID: 3409505.
      Citations: 11     Fields:    Translation:AnimalsCells
    398. Lichstein E, Mendizabal R, Theroux P, Muller O, Willerson JT, Rapaport E, Molk BL, Linet OI. Epoprostenol (prostacyclin) in unstable angina. J Clin Pharmacol. 1988 Apr; 28(4):300-5. PMID: 3292596.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    399. Stone PH, Raabe DS, Jaffe AS, Gustafson N, Muller JE, Turi ZG, Rutherford JD, Poole WK, Passamani E, Willerson JT, et al. Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. J Am Coll Cardiol. 1988 Mar; 11(3):453-63. PMID: 3278032.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    400. Golino P, Ashton JH, Glas-Greenwalt P, McNatt J, Buja LM, Willerson JT. Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis. Circulation. 1988 Mar; 77(3):678-84. PMID: 3124975.
      Citations: 19     Fields:    Translation:AnimalsCells
    401. Willerson JT, Buja LM. Myocardial cellular alterations during myocardial ischemia and evolving infarction. Postgrad Med. 1988 Feb 29; Spec No:69-75. PMID: 2894662.
      Citations: 1     Fields:    Translation:HumansAnimals
    402. Willerson JT, Buja LM. Beta-adrenergic mechanisms during severe myocardial ischemia and evolving infarction. Postgrad Med. 1988 Feb 29; Spec No:27-32. PMID: 2894660.
      Citations:    Fields:    Translation:HumansAnimals
    403. Buja LM, Burton KP, Chien KR, Willerson JT. Altered calcium homeostasis and membrane integrity in myocardial cell injury. Adv Exp Med Biol. 1988; 232:115-24. PMID: 3213680.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    404. Eidt JF, Allison P, Noble S, Ashton J, Golino P, McNatt J, Buja LM, Willerson JT. Thrombin is an important mediator of cyclic coronary blood flow variations due to platelet aggregation in stenosed canine coronary arteries. Trans Assoc Am Physicians. 1988; 101:125-36. PMID: 3269674.
      Citations:    Fields:    Translation:Animals
    405. Tofler GH, Stone PH, Muller JE, Rutherford JD, Willich SN, Gustafson NF, Poole WK, Sobel BE, Willerson JT, Robertson T, et al. Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS Study). Multicenter Investigation of the Limitation of Infarct Size. Am J Cardiol. 1987 Oct 01; 60(10):755-61. PMID: 3661389.
      Citations: 8     Fields:    Translation:Humans
    406. Buja LM, Willerson JT. The role of coronary artery lesions in ischemic heart disease: insights from recent clinicopathologic, coronary arteriographic, and experimental studies. Hum Pathol. 1987 May; 18(5):451-61. PMID: 3552954.
      Citations: 10     Fields:    Translation:Humans
    407. Apprill PG, Ashton J, Guerrero J, Glas-Greenwalt P, Buja LM, Willerson JT. Ancrod decreases the frequency of cyclic flow variations and causes thrombolysis following acute coronary thrombosis. Am Heart J. 1987 Apr; 113(4):898-906. PMID: 3565240.
      Citations: 1     Fields:    Translation:Animals
    408. Jansen DE, Corbett JR, Buja LM, Hansen C, Ugolini V, Parkey RW, Willerson JT. Quantification of myocardial injury produced by temporary coronary artery occlusion and reflow with technetium-99m-pyrophosphate. Circulation. 1987 Mar; 75(3):611-7. PMID: 3493088.
      Citations: 3     Fields:    Translation:Animals
    409. Tofler GH, Stone PH, Muller JE, Willich SN, Davis VG, Poole WK, Strauss HW, Willerson JT, Jaffe AS, Robertson T, et al. Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women. J Am Coll Cardiol. 1987 Mar; 9(3):473-82. PMID: 3819194.
      Citations: 48     Fields:    Translation:Humans
    410. Willerson JT, Winniford M, Buja LM. Thrombolytic therapy for patients with acute myocardial infarction. Am J Med Sci. 1987 Mar; 293(3):187-200. PMID: 3105312.
      Citations:    Fields:    Translation:HumansAnimals
    411. Buja LM, Willerson JT. Infarct size--can it be measured or modified in humans? Prog Cardiovasc Dis. 1987 Jan-Feb; 29(4):271-89. PMID: 2880366.
      Citations: 1     Fields:    Translation:HumansAnimals
    412. Sen A, Buja LM, Willerson JT, Chien KR. Membrane phospholipid metabolism during myocardial ischaemia: past, present and future. Basic Res Cardiol. 1987; 82 Suppl 1:121-5. PMID: 3311000.
      Citations: 3     Fields:    Translation:Animals
    413. Peshock RM, Malloy CR, Buja LM, Nunnally RL, Parkey RW, Willerson JT. Magnetic resonance imaging of acute myocardial infarction: gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion. Circulation. 1986 Dec; 74(6):1434-40. PMID: 3779924.
      Citations: 5     Fields:    Translation:Animals
    414. Keller AM, Jackson JA, Peshock RM, Rehr RB, Willerson JT, Nunnally RL, Buja LM. Nuclear magnetic resonance study of high-energy phosphate stores in models of adriamycin cardiotoxicity. Magn Reson Med. 1986 Dec; 3(6):834-43. PMID: 3821462.
      Citations:    Fields:    Translation:Animals
    415. Stone PH, Turi ZG, Muller JE, Parker C, Hartwell T, Rutherford JD, Jaffe AS, Raabe DS, Passamani ER, Willerson JT, et al. Prognostic significance of the treadmill exercise test performance 6 months after myocardial infarction. J Am Coll Cardiol. 1986 Nov; 8(5):1007-17. PMID: 2876018.
      Citations: 3     Fields:    Translation:Humans
    416. Kennedy PL, Corbett JR, Kulkarni PV, Wolfe CL, Jansen DE, Hansen CL, Buja LM, Parkey RW, Willerson JT. Iodine 123-phenylpentadecanoic acid myocardial scintigraphy: usefulness in the identification of myocardial ischemia. Circulation. 1986 Nov; 74(5):1007-15. PMID: 3769161.
      Citations: 11     Fields:    Translation:Humans
    417. Ashton JH, Schmitz JM, Campbell WB, Ogletree ML, Raheja S, Taylor AL, Fitzgerald C, Buja LM, Willerson JT. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists. Circ Res. 1986 Nov; 59(5):568-78. PMID: 3542279.
      Citations: 17     Fields:    Translation:Animals
    418. Burton KP, Buja LM, Sen A, Willerson JT, Chien KR. Accumulation of arachidonate in triacylglycerols and unesterified fatty acids during ischemia and reflow in the isolated rat heart. Correlation with the loss of contractile function and the development of calcium overload. Am J Pathol. 1986 Aug; 124(2):238-45. PMID: 3090888.
      Citations: 15     Fields:    Translation:Animals
    419. Keller AM, Peshock RM, Malloy CR, Buja LM, Nunnally R, Parkey RW, Willerson JT. In vivo measurement of myocardial mass using nuclear magnetic resonance imaging. J Am Coll Cardiol. 1986 Jul; 8(1):113-7. PMID: 3711507.
      Citations: 12     Fields:    Translation:Animals
    420. Willerson JT, Hillis LD, Winniford M, Buja LM. Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes. J Am Coll Cardiol. 1986 Jul; 8(1):245-50. PMID: 3711523.
      Citations: 19     Fields:    Translation:HumansAnimals
    421. Rude RE, Buja LM, Willerson JT. Propranolol in acute myocardial infarction: the MILIS experience. Am J Cardiol. 1986 Apr 25; 57(12):38F-42F. PMID: 2871744.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    422. Rehr RB, Peshock RM, Malloy CR, Keller AM, Parkey RW, Buja LM, Nunnally RL, Willerson JT. Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration. Am J Cardiol. 1986 Apr 01; 57(10):864-8. PMID: 3962875.
      Citations: 6     Fields:    Translation:Animals
    423. Ashton JH, Benedict CR, Fitzgerald C, Raheja S, Taylor A, Campbell WB, Buja LM, Willerson JT. Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation. 1986 Mar; 73(3):572-8. PMID: 2936531.
      Citations: 28     Fields:    Translation:Animals
    424. Muntz KH, Calianos TA, Vandermolen DT, Willerson JT, Buja LM. Differences in affinity of cardiac beta-adrenergic receptors for [3H]dihydroalprenolol. Am J Physiol. 1986 Mar; 250(3 Pt 2):H490-7. PMID: 3006517.
      Citations: 1     Fields:    Translation:Animals
    425. Gunn MD, Sen A, Chang A, Willerson JT, Buja LM, Chien KR. Mechanisms of accumulation of arachidonic acid in cultured myocardial cells during ATP depletion. Am J Physiol. 1985 Dec; 249(6 Pt 2):H1188-94. PMID: 3934986.
      Citations: 7     Fields:    Translation:AnimalsCells
    426. Willerson JT. Selection of patients for coronary arteriography. Circulation. 1985 Dec; 72(6 Pt 2):V3-8. PMID: 3905056.
      Citations: 1     Fields:    Translation:Humans
    427. Wolfe CL, Jansen DE, Corbett JR, Lipscomb K, Gabliani G, Filipchuk N, Redish G, Lewis SE, Willerson JT. Determination of left ventricular mass using single-photon emission computed tomography. Am J Cardiol. 1985 Nov 01; 56(12):761-4. PMID: 3877448.
      Citations: 4     Fields:    Translation:Humans
    428. Buja LM, Muntz KH, Rosenbaum T, Haghani Z, Buja DK, Sen A, Chien KR, Willerson JT. Characterization of a potentially reversible increase in beta-adrenergic receptors in isolated, neonatal rat cardiac myocytes with impaired energy metabolism. Circ Res. 1985 Oct; 57(4):640-5. PMID: 2994904.
      Citations: 4     Fields:    Translation:AnimalsCells
    429. Buja LM, Hagler HK, Parsons D, Chien K, Reynolds RC, Willerson JT. Alterations of ultrastructure and elemental composition in cultured neonatal rat cardiac myocytes after metabolic inhibition with iodoacetic acid. Lab Invest. 1985 Oct; 53(4):397-412. PMID: 2413276.
      Citations: 14     Fields:    Translation:AnimalsCells
    430. Apprill P, Schmitz JM, Campbell WB, Tilton G, Ashton J, Raheja S, Buja LM, Willerson JT. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors. Circulation. 1985 Aug; 72(2):397-405. PMID: 2988822.
      Citations: 3     Fields:    Translation:Animals
    431. Wheelan K, Wolfe C, Corbett J, Rude RE, Winniford M, Parkey RW, Buja LM, Willerson JT. Early positive technetium-99m stannous pyrophosphate images as a marker of reperfusion after thrombolytic therapy for acute myocardial infarction. Am J Cardiol. 1985 Aug 01; 56(4):252-6. PMID: 4025161.
      Citations: 3     Fields:    Translation:Humans
    432. Bush LR, Buja LM, Tilton G, Wathen M, Apprill P, Ashton J, Willerson JT. Effects of propranolol and diltiazem alone and in combination on the recovery of left ventricular segmental function after temporary coronary occlusion and long-term reperfusion in conscious dogs. Circulation. 1985 Aug; 72(2):413-30. PMID: 4006149.
      Citations: 4     Fields:    Translation:Animals
    433. Schmitz JM, Apprill PG, Buja LM, Willerson JT, Campbell WB. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. Circ Res. 1985 Aug; 57(2):223-31. PMID: 3926340.
      Citations: 15     Fields:    Translation:Animals
    434. Wolfe CL, Lewis SE, Corbett JR, Parkey RW, Buja LM, Willerson JT. Measurement of myocardial infarction fraction using single photon emission computed tomography. J Am Coll Cardiol. 1985 Jul; 6(1):145-51. PMID: 2989347.
      Citations: 2     Fields:    Translation:Animals
    435. Tilton GD, Buja LM, Bilheimer DW, Apprill P, Ashton J, McNatt J, Kita T, Willerson JT. Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia. J Am Coll Cardiol. 1985 Jul; 6(1):141-4. PMID: 4008771.
      Citations: 7     Fields:    Translation:Animals
    436. Chien KR, Sen A, Reynolds R, Chang A, Kim Y, Gunn MD, Buja LM, Willerson JT. Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion. Correlation with the progression of cell injury. J Clin Invest. 1985 Jun; 75(6):1770-80. PMID: 3924955.
      Citations: 17     Fields:    Translation:AnimalsCells
    437. Winniford MD, Willerson JT, Hillis LD. Calcium antagonists for acute ischemic heart disease. Am J Cardiol. 1985 Jan 25; 55(3):116B-124B. PMID: 3881904.
      Citations: 2     Fields:    Translation:Humans
    438. Tilton GD, Bush LR, Apprill PG, Buja LM, Willerson JT. Effect of diltiazem and propranolol on left ventricular segmental relaxation during temporary coronary arterial occlusion and one month reperfusion in conscious dogs. Circulation. 1985 Jan; 71(1):165-75. PMID: 3964719.
      Citations: 2     Fields:    Translation:Animals
    439. Chien KR, Willerson JT, Buja LM. Phospholipid alterations and membrane injury during myocardial ischemia. Adv Myocardiol. 1985; 5:347-53. PMID: 3881812.
      Citations: 1     Fields:    Translation:Animals
    440. Willerson JT, Buja LM. Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarction. Am J Cardiol. 1984 Dec 21; 54(11):16E-20E. PMID: 6150632.
      Citations: 1     Fields:    Translation:HumansAnimalsCTClinical Trials
    441. Corbett JR, Lewis SE, Wolfe CL, Jansen DE, Lewis M, Rellas JS, Parkey RW, Rude RE, Buja LM, Willerson JT. Measurement of myocardial infarct size by technetium pyrophosphate single-photon tomography. Am J Cardiol. 1984 Dec 01; 54(10):1231-6. PMID: 6095634.
      Citations: 7     Fields:    Translation:Humans
    442. Willerson JT, Campbell WB, Winniford MD, Schmitz J, Apprill P, Firth BG, Ashton J, Smitherman T, Bush L, Buja LM. Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. Am J Cardiol. 1984 Dec 01; 54(10):1349-54. PMID: 6391133.
      Citations: 18     Fields:    Translation:Humans
    443. McBride W, Mukherjee A, Haghani Z, Wheeler-Clark E, Brady J, Gandler T, Bush L, Buja LM, Willerson JT. Nitrendipine: effects on vascular responses and myocardial binding. Am J Physiol. 1984 Nov; 247(5 Pt 2):H775-83. PMID: 6093595.
      Citations: 3     Fields:    Translation:AnimalsCells
    444. Bush LR, Campbell WB, Kern K, Tilton GD, Apprill P, Ashton J, Schmitz J, Buja LM, Willerson JT. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries. Circ Res. 1984 Nov; 55(5):642-52. PMID: 6488486.
      Citations: 18     Fields:    Translation:Animals
    445. Jackson JA, Reeves JP, Muntz KH, Kruk D, Prough RA, Willerson JT, Buja LM. Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity. Am J Pathol. 1984 Oct; 117(1):140-53. PMID: 6486242.
      Citations: 10     Fields:    Translation:AnimalsCells
    446. Rellas JS, Sokolov J, Corbett JR, Lewis SE, Willerson JT. Radionuclide ventriculography: usefulness in evaluating alterations in ventricular function. J Mol Cell Cardiol. 1984 Aug; 16(8):695-708. PMID: 6481812.
      Citations:    Fields:    Translation:Humans
    447. Mukharji J, Murray S, Lewis SE, Croft CH, Corbett JR, Willerson JT, Rude RE. Is anterior ST depression with acute transmural inferior infarction due to posterior infarction? A vectorcardiographic and scintigraphic study. J Am Coll Cardiol. 1984 Jul; 4(1):28-34. PMID: 6330194.
      Citations: 3     Fields:    Translation:Humans
    448. Lewis SE, Devous MD, Corbett JR, Izquierdo C, Nicod P, Wolfe CL, Parkey RW, Buja LM, Willerson JT. Measurement of infarct size in acute canine myocardial infarction by single-photon emission computed tomography with technetium-99m pyrophosphate. Am J Cardiol. 1984 Jul 01; 54(1):193-9. PMID: 6331146.
      Citations: 1     Fields:    Translation:Animals
    449. Bush LR, Campbell WB, Buja LM, Tilton GD, Willerson JT. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. Circulation. 1984 Jun; 69(6):1161-70. PMID: 6546902.
      Citations: 17     Fields:    Translation:Animals
    450. Rude RE, Bush LR, Izquierdo C, Buja LM, Willerson JT. Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. III. Influence of basal heart rate. Am J Cardiol. 1984 Jun 01; 53(11):1688-94. PMID: 6428212.
      Citations: 1     Fields:    Translation:Animals
    451. Corbett JR, Lewis M, Willerson JT, Nicod PH, Huxley RL, Simon T, Rude RE, Henderson E, Parkey R, Rellas JS, et al. 99mTc-pyrophosphate imaging in patients with acute myocardial infarction: comparison of planar imaging with single-photon tomography with and without blood pool overlay. Circulation. 1984 Jun; 69(6):1120-8. PMID: 6325039.
      Citations: 13     Fields:    Translation:Humans
    452. Wolfe CL, Corbett JR, Lewis SE, Buja LM, Willerson JT. Determination of left ventricular mass by single-photon emission computed tomography with thallium-201. Am J Cardiol. 1984 May 01; 53(9):1365-8. PMID: 6608870.
      Citations: 2     Fields:    Translation:Animals
    453. Chien KR, Han A, Sen A, Buja LM, Willerson JT. Accumulation of unesterified arachidonic acid in ischemic canine myocardium. Relationship to a phosphatidylcholine deacylation-reacylation cycle and the depletion of membrane phospholipids. Circ Res. 1984 Mar; 54(3):313-22. PMID: 6421507.
      Citations: 64     Fields:    Translation:AnimalsCells
    454. Muntz KH, Olson EG, Lariviere GR, D'Souza S, Mukherjee A, Willerson JT, Buja LM. Autoradiographic characterization of beta adrenergic receptors in coronary blood vessels and myocytes in normal and ischemic myocardium of the canine heart. J Clin Invest. 1984 Feb; 73(2):349-57. PMID: 6321553.
      Citations: 2     Fields:    Translation:Animals
    455. Hagler HK, Burton KP, Willerson JT, Buja LM. New techniques for the elemental analysis of the myocardium: application to the study of ischemia. Ann N Y Acad Sci. 1984; 428:68-81. PMID: 6588912.
      Citations:    Fields:    Translation:AnimalsCells
    456. Nicod P, Corbett JR, Sanford CF, Mukharji J, Dehmer GJ, Croft CH, Rude RE, Lewis S, Willerson JT. Comparison of the influence of acute transmural and nontransmural myocardial infarction on ventricular function. Am Heart J. 1984 Jan; 107(1):28-34. PMID: 6691238.
      Citations: 2     Fields:    Translation:Humans
    457. Muntz KH, Hagler HK, Boulas HJ, Willerson JT, Buja LM. Redistribution of catecholamines in the ischemic zone of the dog heart. Am J Pathol. 1984 Jan; 114(1):64-78. PMID: 6691416.
      Citations: 5     Fields:    Translation:Animals
    458. Mukherjee A, Haghani Z, Brady J, Bush L, McBride W, Buja LM, Willerson JT. Differences in myocardial alpha- and beta-adrenergic receptor numbers in different species. Am J Physiol. 1983 Dec; 245(6):H957-61. PMID: 6318573.
      Citations: 20     Fields:    Translation:AnimalsCells
    459. Rellas JS, Corbett JR, Kulkarni P, Morgan C, Devous MD, Buja LM, Bush L, Parkey RW, Willerson JT, Lewis SE. Iodine-123 phenylpentadecanoic acid: detection of acute myocardial infarction and injury in dogs using an iodinated fatty acid and single-photon emission tomography. Am J Cardiol. 1983 Dec 01; 52(10):1326-32. PMID: 6606352.
      Citations: 8     Fields:    Translation:Animals
    460. Mauritson DR, Johnson SM, Winniford MD, Cary JR, Willerson JT, Hillis LD. Verapamil for unstable angina at rest: a short-term randomized, double-blind study. Am Heart J. 1983 Oct; 106(4 Pt 1):652-8. PMID: 6613808.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    461. Tilton GD, Bush L, Wathen M, Buja LM, Willerson JT. What's wrong with the failing heart? Tex Med. 1983 Oct; 79(10):35-8. PMID: 6227103.
      Citations:    Fields:    Translation:Humans
    462. Chien KR, Sen A, Buja LM, Willerson JT. Fatty acylcarnitine accumulation and membrane injury in ischemic canine myocardium. Am J Cardiol. 1983 Oct 01; 52(7):893-7. PMID: 6624683.
      Citations: 1     Fields:    Translation:AnimalsCells
    463. Buja LM, Burton KP, Hagler HK, Willerson JT. Quantitative x-ray microanalysis of the elemental composition of individual myocytes in hypoxic rabbit myocardium. Circulation. 1983 Oct; 68(4):872-82. PMID: 6616782.
      Citations: 4     Fields:    Translation:AnimalsCells
    464. Rude RE, Izquierdo C, Bush LR, Buja LM, Willerson JT. Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. II. Studies with dopamine and ouabain in the barbiturate-anesthetized dog. J Cardiovasc Pharmacol. 1983 Sep-Oct; 5(5):717-24. PMID: 6195456.
      Citations: 1     Fields:    Translation:Animals
    465. Bush LR, Buja LM, Samowitz W, Rude RE, Wathen M, Tilton GD, Willerson JT. Recovery of left ventricular segmental function after long-term reperfusion following temporary coronary occlusion in conscious dogs. Comparison of 2- and 4-hour occlusions. Circ Res. 1983 Aug; 53(2):248-63. PMID: 6883648.
      Citations: 9     Fields:    Translation:Animals
    466. Stone MJ, Willerson JT. Myoglobinemia in myocardial infarction. Int J Cardiol. 1983 Aug; 4(1):49-52. PMID: 6618718.
      Citations: 5     Fields:    Translation:HumansAnimals
    467. Rude RE, Croft CH, Willerson JT. "Reciprocal" anterior ST depression early in the course of transmural inferior myocardial infarction: an ECG finding of uncertain clinical significance. Int J Cardiol. 1983 Aug; 4(1):80-5. PMID: 6618723.
      Citations: 1     Fields:    Translation:Humans
    468. Corbett JR, Nicod P, Lewis SE, Rude RE, Willerson JT. Prognostic value of submaximal exercise radionuclide ventriculography after myocardial infarction. Am J Cardiol. 1983 Jul 20; 52(2):82A-91A. PMID: 6869261.
      Citations: 5     Fields:    Translation:Humans
    469. Nicod P, Corbett JR, Firth BG, Lewis SE, Rude RE, Huxley R, Willerson JT. Prognostic value of resting and submaximal exercise radionuclide ventriculography after acute myocardial infarction in high-risk patients with single and multivessel disease. Am J Cardiol. 1983 Jul; 52(1):30-6. PMID: 6858923.
      Citations: 7     Fields:    Translation:Humans
    470. Izquierdo C, Devous MD, Nicod P, Buja LM, Parkey RW, Bonte FJ, Willerson JT, Lewis SE. A comparison of infarct identification with technetium-99m pyrophosphate and staining with triphenyl tetrazolium chloride. J Nucl Med. 1983 Jun; 24(6):492-7. PMID: 6304264.
      Citations: 1     Fields:    Translation:Animals
    471. Huxley RL, Gaffney FA, Corbett JR, Firth BG, Peshock R, Nicod P, Rellas JS, Curry G, Lewis SE, Willerson JT. Early detection of left ventricular dysfunction in chronic aortic regurgitation as assessed by contrast angiography, echocardiography, and rest and exercise scintigraphy. Am J Cardiol. 1983 May 15; 51(9):1542-50. PMID: 6846190.
      Citations: 1     Fields:    Translation:Humans
    472. Corbett JR, Nicod PH, Huxley RL, Lewis SE, Rude RE, Willerson JT. Left ventricular functional alterations at rest and during submaximal exercise in patients with recent myocardial infarction. Am J Med. 1983 Apr; 74(4):577-91. PMID: 6837586.
      Citations:    Fields:    Translation:Humans
    473. Hirsh PD, Firth BG, Campbell WB, Dehmer GJ, Willerson JT, Hillis LD. Effects of provocation on transcardiac thromboxane in patients with coronary artery disease. Am J Cardiol. 1983 Mar 01; 51(5):727-33. PMID: 6829431.
      Citations: 1     Fields:    Translation:Humans
    474. Buja LM, Chien KR, Burton KP, Hagler HK, Mukherjee A, Willerson JT. Membrane damage in ischemia. Adv Exp Med Biol. 1983; 161:421-31. PMID: 6135307.
      Citations: 1     Fields:    Translation:AnimalsCells
    475. Bush LR, Campbell WB, Tilton GD, Buja LM, Willerson JT. Effects of the selective thromboxane synthetase inhibitor, dazoxiben, on cyclic flow variations in stenosed canine coronary arteries. Trans Assoc Am Physicians. 1983; 96:103-12. PMID: 6687298.
      Citations: 1     Fields:    Translation:Animals
    476. Willerson JT. How reliable is myocardial imaging in the diagnosis of acute myocardial infarction? Cardiovasc Clin. 1983; 13(1):33-50. PMID: 6336673.
      Citations:    Fields:    Translation:HumansAnimals